ID   OGA_HUMAN               Reviewed;         916 AA.
AC   O60502; B7WPB9; D3DR79; E9PGF9; O75166; Q86WV0; Q8IV98; Q9BVA5; Q9HAR0;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 2.
DT   10-FEB-2021, entry version 168.
DE   RecName: Full=Protein O-GlcNAcase {ECO:0000303|PubMed:11148210, ECO:0000303|PubMed:11788610, ECO:0000305};
DE            Short=OGA {ECO:0000303|PubMed:20863279};
DE            EC=3.2.1.169 {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:18586680, ECO:0000269|PubMed:20863279, ECO:0000269|PubMed:22365600, ECO:0000305|PubMed:20673219};
DE   AltName: Full=Beta-N-acetylglucosaminidase {ECO:0000303|PubMed:11148210};
DE   AltName: Full=Beta-N-acetylhexosaminidase;
DE   AltName: Full=Beta-hexosaminidase;
DE   AltName: Full=Meningioma-expressed antigen 5 {ECO:0000303|PubMed:9811929};
DE   AltName: Full=N-acetyl-beta-D-glucosaminidase;
DE   AltName: Full=N-acetyl-beta-glucosaminidase;
DE   AltName: Full=Nuclear cytoplasmic O-GlcNAcase and acetyltransferase;
DE            Short=NCOAT;
GN   Name=OGA {ECO:0000312|HGNC:HGNC:7056, ECO:0000303|Ref.3};
GN   Synonyms=HEXC, KIAA0679, MEA5, MGEA5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Meningioma;
RX   PubMed=9811929; DOI=10.1093/hmg/7.12.1859;
RA   Heckel D., Comtesse N., Brass N., Blin N., Zang K.D., Meese E.;
RT   "Novel immunogenic antigen homologous to hyaluronidase in meningioma.";
RL   Hum. Mol. Genet. 7:1859-1872(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3), SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=11341771; DOI=10.1006/bbrc.2001.4815;
RA   Comtesse N., Maldener E., Meese E.;
RT   "Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase
RT   and a beta-N-acetylglucosaminidase.";
RL   Biochem. Biophys. Res. Commun. 283:634-640(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   ACTIVITY REGULATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain;
RX   PubMed=11148210; DOI=10.1074/jbc.m010420200;
RA   Gao Y., Wells L., Comer F.I., Parker G.J., Hart G.W.;
RT   "Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and
RT   characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from
RT   human brain.";
RL   J. Biol. Chem. 276:9838-9845(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LYS-602.
RC   TISSUE=Cervix, Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, PTM,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=11788610; DOI=10.1074/jbc.m109656200;
RA   Wells L., Gao Y., Mahoney J.A., Vosseller K., Chen C., Rosen A., Hart G.W.;
RT   "Dynamic O-glycosylation of nuclear and cytosolic proteins: further
RT   characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-
RT   GlcNAcase.";
RL   J. Biol. Chem. 277:1755-1761(2002).
RN   [10]
RP   ACTIVE SITE, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-174 AND ASP-175.
RX   PubMed=16533067; DOI=10.1021/bi052370b;
RA   Cetinbas N., Macauley M.S., Stubbs K.A., Drapala R., Vocadlo D.J.;
RT   "Identification of Asp174 and Asp175 as the key catalytic residues of human
RT   O-GlcNAcase by functional analysis of site-directed mutants.";
RL   Biochemistry 45:3835-3844(2006).
RN   [11]
RP   PTM, SITE, MUTAGENESIS OF ASP-413, AND CATALYTIC ACTIVITY.
RX   PubMed=18586680; DOI=10.1074/jbc.m804116200;
RA   Butkinaree C., Cheung W.D., Park S., Park K., Barber M., Hart G.W.;
RT   "Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3
RT   during apoptosis.";
RL   J. Biol. Chem. 283:23557-23566(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF TYR-69; ASP-175; VAL-255;
RP   TYR-286; ASP-287 AND TRP-679.
RX   PubMed=20863279; DOI=10.1042/bj20101338;
RA   Schimpl M., Schuttelkopf A.W., Borodkin V.S., van Aalten D.M.;
RT   "Human OGA binds substrates in a conserved peptide recognition groove.";
RL   Biochem. J. 432:1-7(2010).
RN   [16]
RP   FUNCTION OF ISOFORMS 1 AND 3, AND CATALYTIC ACTIVITY.
RX   PubMed=20673219; DOI=10.1134/s0006297910070175;
RA   Li J., Huang C.L., Zhang L.W., Lin L., Li Z.H., Zhang F.W., Wang P.;
RT   "Isoforms of human O-GlcNAcase show distinct catalytic efficiencies.";
RL   Biochemistry (Mosc.) 75:938-943(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   LACK OF ACETYLTRANSFERASE ACTIVITY, AND FUNCTION.
RX   PubMed=24088714; DOI=10.1098/rsob.130021;
RA   Rao F.V., Schuttelkopf A.W., Dorfmueller H.C., Ferenbach A.T.,
RA   Navratilova I., van Aalten D.M.;
RT   "Structure of a bacterial putative acetyltransferase defines the fold of
RT   the human O-GlcNAcase C-terminal domain.";
RL   Open Biol. 3:130021-130021(2013).
RN   [23]
RP   INTERACTION WITH HUMAN T-CELL LEUKEMIA VIRUS 1/HTLV-1 PROTEIN TAX.
RX   PubMed=28742148; DOI=10.1371/journal.ppat.1006518;
RA   Groussaud D., Khair M., Tollenaere A.I., Waast L., Kuo M.S., Mangeney M.,
RA   Martella C., Fardini Y., Coste S., Souidi M., Benit L., Pique C., Issad T.;
RT   "Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein
RT   facilitates viral transcription.";
RL   PLoS Pathog. 13:E1006518-E1006518(2017).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 402-408, MUTAGENESIS OF TYR-69,
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=22365600; DOI=10.1016/j.chembiol.2012.01.011;
RA   Schimpl M., Borodkin V.S., Gray L.J., van Aalten D.M.;
RT   "Synergy of peptide and sugar in O-GlcNAcase substrate recognition.";
RL   Chem. Biol. 19:173-178(2012).
CC   -!- FUNCTION: [Isoform 1]: Cleaves GlcNAc but not GalNAc from O-
CC       glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc and 4-
CC       methylumbelliferone-GlcNAc as substrates but not p-nitrophenyl-beta-
CC       GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro) (PubMed:11148210). Does
CC       not bind acetyl-CoA and does not have histone acetyltransferase
CC       activity (PubMed:24088714). {ECO:0000269|PubMed:11148210,
CC       ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:20673219,
CC       ECO:0000269|PubMed:22365600, ECO:0000269|PubMed:24088714}.
CC   -!- FUNCTION: [Isoform 3]: Cleaves GlcNAc but not GalNAc from O-
CC       glycosylated proteins. Can use p-nitrophenyl-beta-GlcNAc as substrate
CC       but not p-nitrophenyl-beta-GalNAc or p-nitrophenyl-alpha-GlcNAc (in
CC       vitro), but has about six times lower specific activity than isoform 1.
CC       {ECO:0000269|PubMed:20673219}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-(N-acetyl-beta-D-glucosaminyl)-L-seryl-[protein] + H2O =
CC         L-seryl-[protein] + N-acetyl-D-glucosamine; Xref=Rhea:RHEA:48876,
CC         Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12251, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:29999, ChEBI:CHEBI:90838, ChEBI:CHEBI:506227;
CC         EC=3.2.1.169; Evidence={ECO:0000269|PubMed:11148210,
CC         ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:18586680,
CC         ECO:0000269|PubMed:20863279, ECO:0000269|PubMed:22365600,
CC         ECO:0000305|PubMed:20673219};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonyl-[protein] + H2O
CC         = L-threonyl-[protein] + N-acetyl-D-glucosamine;
CC         Xref=Rhea:RHEA:48892, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:12252,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:90840,
CC         ChEBI:CHEBI:506227; EC=3.2.1.169;
CC         Evidence={ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11788610,
CC         ECO:0000269|PubMed:18586680, ECO:0000269|PubMed:20863279,
CC         ECO:0000269|PubMed:22365600, ECO:0000305|PubMed:20673219};
CC   -!- ACTIVITY REGULATION: Inhibited by N-acetylglucosamine and not N-
CC       acetylgalactosamine. {ECO:0000269|PubMed:11148210}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.1 mM for pNP-GlcNAc {ECO:0000269|PubMed:11788610};
CC         Vmax=652 umol/min/mg enzyme with pNP-GLcNAc as substrate
CC         {ECO:0000269|PubMed:11788610};
CC       pH dependence:
CC         Optimum pH is 5.7-7. {ECO:0000269|PubMed:11148210};
CC   -!- SUBUNIT: Monomer (PubMed:11788610). Interacts with CLOCK (By
CC       similarity). {ECO:0000250|UniProtKB:Q9EQQ9,
CC       ECO:0000269|PubMed:11788610}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human T-cell leukemia
CC       virus 1/HTLV-1 protein Tax; this interaction increases Tax interacting
CC       partner CREB1 O-GlcNAcylation. {ECO:0000269|PubMed:28742148}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Nucleus
CC       {ECO:0000269|PubMed:11341771}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm
CC       {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11341771,
CC       ECO:0000269|PubMed:11788610}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O60502-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60502-2; Sequence=VSP_020866, VSP_020869;
CC       Name=3; Synonyms=MGEA5s;
CC         IsoId=O60502-3; Sequence=VSP_020867, VSP_020868;
CC       Name=4;
CC         IsoId=O60502-4; Sequence=VSP_020866;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Shows highest expression in the brain,
CC       placenta and pancreas. {ECO:0000269|PubMed:11148210,
CC       ECO:0000269|PubMed:11341771}.
CC   -!- PTM: Proteolytically cleaved by caspase-3 during apoptosis. The
CC       fragments interact with each other; cleavage does not decrease enzyme
CC       activity. {ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:18586680}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 84 family. {ECO:0000305}.
CC   -!- CAUTION: The mouse and rat orthologs were initially identified as bi-
CC       functional proteins containing an N-terminal domain with O-GlcNAcase
CC       activity and a C-terminal domain with histone acetyltransferase
CC       activity. The histone acetyltransferase activity was detected only when
CC       the protein was expressed in mammalian cells, but not when expressed in
CC       bacterial cells, suggesting that the histone acetyltransferase activity
CC       might be due to the presence of a contaminant. Comparison of the human
CC       protein with a bacterial putative acetyltransferase (AC Q2CEE2) shows
CC       that the residues important for acetyl-CoA binding are not conserved,
CC       and that the residues proposed to be important for histone
CC       acetyltransferase activity are not in a position where they could
CC       participate in catalysis. Characterization of the human protein shows
CC       that it does not bind acetyl-CoA and therefore cannot have
CC       acetyltransferase activity. {ECO:0000269|PubMed:24088714,
CC       ECO:0000305|PubMed:24088714}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH47877.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA31654.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF036144; AAD05385.2; -; mRNA.
DR   EMBL; AF307332; AAG21428.1; -; mRNA.
DR   EMBL; AB014579; BAA31654.2; ALT_INIT; mRNA.
DR   EMBL; AC010789; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49744.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49741.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49742.1; -; Genomic_DNA.
DR   EMBL; BC001343; AAH01343.1; -; mRNA.
DR   EMBL; BC039583; AAH39583.2; -; mRNA.
DR   EMBL; BC047877; AAH47877.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS44471.1; -. [O60502-4]
DR   CCDS; CCDS7520.1; -. [O60502-1]
DR   PIR; T00360; T00360.
DR   RefSeq; NP_001135906.1; NM_001142434.1. [O60502-4]
DR   RefSeq; NP_036347.1; NM_012215.3. [O60502-1]
DR   PDB; 2YDQ; X-ray; 2.60 A; T=402-408.
DR   PDB; 5M7R; X-ray; 2.35 A; A/B=1-916.
DR   PDB; 5M7S; X-ray; 2.40 A; A/B=1-916.
DR   PDB; 5M7T; X-ray; 2.60 A; A/B=1-916.
DR   PDB; 5M7U; X-ray; 2.30 A; A/B=1-916.
DR   PDB; 5TKE; X-ray; 2.48 A; A/B=60-400, A/B=553-704.
DR   PDB; 5UHK; X-ray; 2.97 A; A/C=56-400, B/D=544-705.
DR   PDB; 5UHL; X-ray; 3.14 A; A/C=56-400, B/D=544-705.
DR   PDB; 5UHO; X-ray; 3.21 A; A/C=56-400, B/D=544-705.
DR   PDB; 5UHP; X-ray; 2.79 A; A/B/C/D=14-400, E/F/G/H=554-705.
DR   PDB; 5UN8; X-ray; 2.13 A; A/B/C/D=60-400, A/B/C/D=553-704.
DR   PDB; 5UN9; X-ray; 2.50 A; A/B=60-400, A/B=553-704.
DR   PDB; 5VVO; X-ray; 2.60 A; A/B=60-400, A/B=553-704.
DR   PDB; 5VVT; X-ray; 2.80 A; A/C=60-400, A/C=553-704.
DR   PDB; 5VVU; X-ray; 2.70 A; A/C=60-400, A/C=553-704.
DR   PDB; 5VVV; X-ray; 2.80 A; A/C=60-400, A/C=553-704.
DR   PDB; 5VVX; X-ray; 2.90 A; A/C=60-400, A/C=553-704.
DR   PDB; 6HKI; X-ray; 3.30 A; A/B=1-916.
DR   PDB; 6PM9; X-ray; 2.86 A; A/B/C/D=14-400, E/F/G/H=553-705.
DR   PDBsum; 2YDQ; -.
DR   PDBsum; 5M7R; -.
DR   PDBsum; 5M7S; -.
DR   PDBsum; 5M7T; -.
DR   PDBsum; 5M7U; -.
DR   PDBsum; 5TKE; -.
DR   PDBsum; 5UHK; -.
DR   PDBsum; 5UHL; -.
DR   PDBsum; 5UHO; -.
DR   PDBsum; 5UHP; -.
DR   PDBsum; 5UN8; -.
DR   PDBsum; 5UN9; -.
DR   PDBsum; 5VVO; -.
DR   PDBsum; 5VVT; -.
DR   PDBsum; 5VVU; -.
DR   PDBsum; 5VVV; -.
DR   PDBsum; 5VVX; -.
DR   PDBsum; 6HKI; -.
DR   PDBsum; 6PM9; -.
DR   SMR; O60502; -.
DR   BioGRID; 115948; 44.
DR   IntAct; O60502; 34.
DR   MINT; O60502; -.
DR   STRING; 9606.ENSP00000354850; -.
DR   BindingDB; O60502; -.
DR   ChEMBL; CHEMBL5921; -.
DR   DrugBank; DB00428; Streptozocin.
DR   GuidetoPHARMACOLOGY; 3101; -.
DR   CAZy; GH84; Glycoside Hydrolase Family 84.
DR   GlyGen; O60502; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O60502; -.
DR   MetOSite; O60502; -.
DR   PhosphoSitePlus; O60502; -.
DR   SwissPalm; O60502; -.
DR   BioMuta; MGEA5; -.
DR   CPTAC; CPTAC-1223; -.
DR   EPD; O60502; -.
DR   jPOST; O60502; -.
DR   MassIVE; O60502; -.
DR   MaxQB; O60502; -.
DR   PaxDb; O60502; -.
DR   PeptideAtlas; O60502; -.
DR   PRIDE; O60502; -.
DR   ProteomicsDB; 20314; -.
DR   ProteomicsDB; 49438; -. [O60502-1]
DR   ProteomicsDB; 49439; -. [O60502-2]
DR   ProteomicsDB; 49440; -. [O60502-3]
DR   Antibodypedia; 31340; 166 antibodies.
DR   DNASU; 10724; -.
DR   Ensembl; ENST00000357797; ENSP00000350445; ENSG00000198408. [O60502-2]
DR   Ensembl; ENST00000361464; ENSP00000354850; ENSG00000198408. [O60502-1]
DR   Ensembl; ENST00000370094; ENSP00000359112; ENSG00000198408. [O60502-3]
DR   Ensembl; ENST00000439817; ENSP00000409973; ENSG00000198408. [O60502-4]
DR   GeneID; 10724; -.
DR   KEGG; hsa:10724; -.
DR   UCSC; uc001ktv.3; human. [O60502-1]
DR   CTD; 10724; -.
DR   DisGeNET; 10724; -.
DR   GeneCards; OGA; -.
DR   HGNC; HGNC:7056; OGA.
DR   HPA; ENSG00000198408; Low tissue specificity.
DR   MIM; 604039; gene.
DR   neXtProt; NX_O60502; -.
DR   OpenTargets; ENSG00000198408; -.
DR   PharmGKB; PA30787; -.
DR   VEuPathDB; HostDB:ENSG00000198408.13; -.
DR   eggNOG; KOG3698; Eukaryota.
DR   GeneTree; ENSGT00390000007726; -.
DR   HOGENOM; CLU_009837_1_0_1; -.
DR   InParanoid; O60502; -.
DR   OMA; QFGCEAY; -.
DR   OrthoDB; 159999at2759; -.
DR   PhylomeDB; O60502; -.
DR   TreeFam; TF313732; -.
DR   BioCyc; MetaCyc:HS03036-MONOMER; -.
DR   BRENDA; 3.2.1.35; 2681.
DR   PathwayCommons; O60502; -.
DR   BioGRID-ORCS; 10724; 97 hits in 881 CRISPR screens.
DR   ChiTaRS; MGEA5; human.
DR   GeneWiki; MGEA5; -.
DR   GenomeRNAi; 10724; -.
DR   Pharos; O60502; Tchem.
DR   PRO; PR:O60502; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; O60502; protein.
DR   Bgee; ENSG00000198408; Expressed in forebrain and 244 other tissues.
DR   ExpressionAtlas; O60502; baseline and differential.
DR   Genevisible; O60502; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0102167; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102571; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102166; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016231; F:beta-N-acetylglucosaminidase activity; IDA:UniProtKB.
DR   GO; GO:0004415; F:hyalurononglucosaminidase activity; TAS:ProtInc.
DR   GO; GO:0006516; P:glycoprotein catabolic process; TAS:ProtInc.
DR   GO; GO:0009100; P:glycoprotein metabolic process; IBA:GO_Central.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006517; P:protein deglycosylation; IDA:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   DisProt; DP02479; -.
DR   IDEAL; IID00643; -.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR011496; Beta-N-acetylglucosaminidase.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   Pfam; PF07555; NAGidase; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Glycosidase;
KW   Host-virus interaction; Hydrolase; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..916
FT                   /note="Protein O-GlcNAcase"
FT                   /id="PRO_0000252118"
FT   REGION          278..280
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q2CEE3"
FT   ACT_SITE        175
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:16533067"
FT   BINDING         67
FT                   /note="Substrate; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q2CEE3"
FT   BINDING         98
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         174
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         219
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q2CEE3"
FT   BINDING         285
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q2CEE3"
FT   BINDING         313
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q2CEE3"
FT   SITE            413..414
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000269|PubMed:18586680"
FT   MOD_RES         364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         346..398
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020866"
FT   VAR_SEQ         663..677
FT                   /note="CRSHSSAQFLIGDQE -> RCTRNNLFSSNILSL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9811929"
FT                   /id="VSP_020867"
FT   VAR_SEQ         678..916
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9811929"
FT                   /id="VSP_020868"
FT   VAR_SEQ         691..704
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020869"
FT   VARIANT         46
FT                   /note="G -> E (in dbSNP:rs3740421)"
FT                   /id="VAR_027761"
FT   VARIANT         602
FT                   /note="E -> K (in dbSNP:rs17853930)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027762"
FT   MUTAGEN         69
FT                   /note="Y->K,Q: Strongly reduces affinity for glycopeptide
FT                   substrates. Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:20863279,
FT                   ECO:0000269|PubMed:22365600"
FT   MUTAGEN         69
FT                   /note="Y->S: Strongly reduces affinity for glycopeptide
FT                   substrates. Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:20863279,
FT                   ECO:0000269|PubMed:22365600"
FT   MUTAGEN         174
FT                   /note="D->A: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:16533067"
FT   MUTAGEN         175
FT                   /note="D->A: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:16533067"
FT   MUTAGEN         175
FT                   /note="D->N: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:20863279"
FT   MUTAGEN         255
FT                   /note="V->G,T: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:20863279"
FT   MUTAGEN         286
FT                   /note="Y->S: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:20863279"
FT   MUTAGEN         287
FT                   /note="D->A: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:20863279"
FT   MUTAGEN         413
FT                   /note="D->A: Abrogates cleavage by caspase-3."
FT                   /evidence="ECO:0000269|PubMed:18586680"
FT   MUTAGEN         679
FT                   /note="W->N: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:20863279"
FT   TURN            50..52
FT                   /evidence="ECO:0000244|PDB:6PM9"
FT   TURN            54..57
FT                   /evidence="ECO:0000244|PDB:5UHP"
FT   STRAND          61..66
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          69..71
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           75..87
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          92..95
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           101..103
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            104..108
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           113..128
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          132..137
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            140..142
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           148..162
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            163..165
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          168..172
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           182..187
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          188..190
FT                   /evidence="ECO:0000244|PDB:5VVU"
FT   HELIX           191..205
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          212..215
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           221..223
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          224..226
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            228..230
FT                   /evidence="ECO:0000244|PDB:5M7R"
FT   HELIX           232..240
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          245..249
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          252..255
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           261..271
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          276..279
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           285..287
FT                   /evidence="ECO:0000244|PDB:5UHK"
FT   HELIX           301..306
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   STRAND          308..312
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           318..321
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           322..332
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            334..337
FT                   /evidence="ECO:0000244|PDB:5UHL"
FT   HELIX           376..388
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            389..391
FT                   /evidence="ECO:0000244|PDB:5M7R"
FT   STRAND          542..544
FT                   /evidence="ECO:0000244|PDB:5M7T"
FT   HELIX           555..564
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           573..587
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           589..591
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            601..603
FT                   /evidence="ECO:0000244|PDB:6HKI"
FT   HELIX           605..628
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           634..661
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            662..666
FT                   /evidence="ECO:0000244|PDB:5M7R"
FT   TURN            680..683
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   HELIX           684..692
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            694..699
FT                   /evidence="ECO:0000244|PDB:5UN8"
FT   TURN            710..712
FT                   /evidence="ECO:0000244|PDB:5M7R"
SQ   SEQUENCE   916 AA;  102915 MW;  01F8A64A9B1475C6 CRC64;
     MVQKESQATL EERESELSSN PAASAGASLE PPAAPAPGED NPAGAGGAAV AGAAGGARRF
     LCGVVEGFYG RPWVMEQRKE LFRRLQKWEL NTYLYAPKDD YKHRMFWREM YSVEEAEQLM
     TLISAAREYE IEFIYAISPG LDITFSNPKE VSTLKRKLDQ VSQFGCRSFA LLFDDIDHNM
     CAADKEVFSS FAHAQVSITN EIYQYLGEPE TFLFCPTEYC GTFCYPNVSQ SPYLRTVGEK
     LLPGIEVLWT GPKVVSKEIP VESIEEVSKI IKRAPVIWDN IHANDYDQKR LFLGPYKGRS
     TELIPRLKGV LTNPNCEFEA NYVAIHTLAT WYKSNMNGVR KDVVMTDSED STVSIQIKLE
     NEGSDEDIET DVLYSPQMAL KLALTEWLQE FGVPHQYSSR QVAHSGAKAS VVDGTPLVAA
     PSLNATTVVT TVYQEPIMSQ GAALSGEPTT LTKEEEKKQP DEEPMDMVVE KQEETDHKND
     NQILSEIVEA KMAEELKPMD TDKESIAESK SPEMSMQEDC ISDIAPMQTD EQTNKEQFVP
     GPNEKPLYTA EPVTLEDLQL LADLFYLPYE HGPKGAQMLR EFQWLRANSS VVSVNCKGKD
     SEKIEEWRSR AAKFEEMCGL VMGMFTRLSN CANRTILYDM YSYVWDIKSI MSMVKSFVQW
     LGCRSHSSAQ FLIGDQEPWA FRGGLAGEFQ RLLPIDGAND LFFQPPPLTP TSKVYTIRPY
     FPKDEASVYK ICREMYDDGV GLPFQSQPDL IGDKLVGGLL SLSLDYCFVL EDEDGICGYA
     LGTVDVTPFI KKCKISWIPF MQEKYTKPNG DKELSEAEKI MLSFHEEQEV LPETFLANFP
     SLIKMDIHKK VTDPSVAKSM MACLLSSLKA NGSRGAFCEV RPDDKRILEF YSKLGCFEIA
     KMEGFPKDVV ILGRSL
//
ID   OSB11_HUMAN             Reviewed;         747 AA.
AC   Q9BXB4; A8K9I7;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   11-FEB-2002, sequence version 2.
DT   10-FEB-2021, entry version 159.
DE   RecName: Full=Oxysterol-binding protein-related protein 11;
DE            Short=ORP-11;
DE            Short=OSBP-related protein 11;
GN   Name=OSBPL11; Synonyms=ORP11, OSBP12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11735225; DOI=10.1006/geno.2001.6663;
RA   Jaworski C.J., Moreira E., Li A., Lee R., Rodriguez I.R.;
RT   "A family of 12 human genes containing oxysterol-binding domains.";
RL   Genomics 78:185-196(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-315.
RX   PubMed=11483621;
RA   Lehto M., Laitinen S., Chinetti G., Johansson M., Ehnholm C., Staels B.,
RA   Ikonen E., Olkkonen V.M.;
RT   "The OSBP-related protein family in humans.";
RL   J. Lipid Res. 42:1203-1213(2001).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=17428193; DOI=10.1042/bj20070176;
RA   Suchanek M., Hynynen R., Wohlfahrt G., Lehto M., Johansson M., Saarinen H.,
RA   Radzikowska A., Thiele C., Olkkonen V.M.;
RT   "The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-
RT   hydroxycholesterol in an evolutionarily conserved pocket.";
RL   Biochem. J. 405:473-480(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-27, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-27; SER-181 AND SER-189, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-27; TYR-62; SER-172; SER-174
RP   AND SER-181, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20599956; DOI=10.1016/j.yexcr.2010.06.008;
RA   Zhou Y., Li S., Mayranpaa M.I., Zhong W., Back N., Yan D., Olkkonen V.M.;
RT   "OSBP-related protein 11 (ORP11) dimerizes with ORP9 and localizes at the
RT   Golgi-late endosome interface.";
RL   Exp. Cell Res. 316:3304-3316(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-27; SER-181 AND SER-189, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=23028956; DOI=10.1371/journal.pone.0045352;
RA   Zhou Y., Robciuc M.R., Wabitsch M., Juuti A., Leivonen M., Ehnholm C.,
RA   Yki-Jarvinen H., Olkkonen V.M.;
RT   "OSBP-related proteins (ORPs) in human adipose depots and cultured
RT   adipocytes: evidence for impacts on the adipocyte phenotype.";
RL   PLoS ONE 7:E45352-E45352(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; THR-27; SER-172; SER-174;
RP   SER-181; SER-184 AND SER-189, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; SER-172 AND SER-181, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   STRUCTURE BY NMR OF 59-165.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the PH domain of oxysterol binding protein-related
RT   protein 11 from human.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-184.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Plays a role in regulating ADIPOQ and FABP4 levels in
CC       differentiating adipocytes and is also involved in regulation of
CC       adipocyte triglyceride storage (PubMed:23028956). Weakly binds 25-
CC       hydroxycholesterol (PubMed:17428193). {ECO:0000269|PubMed:17428193,
CC       ECO:0000269|PubMed:23028956}.
CC   -!- SUBUNIT: Heterodimer with OSBPL9. {ECO:0000269|PubMed:20599956}.
CC   -!- INTERACTION:
CC       Q9BXB4; Q96SU4: OSBPL9; NbExp=7; IntAct=EBI-2514786, EBI-2511368;
CC   -!- SUBCELLULAR LOCATION: Late endosome membrane
CC       {ECO:0000269|PubMed:20599956}. Golgi apparatus, trans-Golgi network
CC       membrane {ECO:0000269|PubMed:20599956}. Note=Localizes at the Golgi-
CC       late endosome interface.
CC   -!- TISSUE SPECIFICITY: Present at highest levels in ovary, testis, kidney,
CC       liver, stomach, brain, and adipose tissue. Strong expression (at
CC       protein level) in epithelial cells of kidney tubules, testicular
CC       tubules, caecum, and skin (PubMed:20599956). Present at low levels in
CC       subcutaneous and visceral adipose tissue (at protein
CC       level)(PubMed:23028956). {ECO:0000269|PubMed:20599956,
CC       ECO:0000269|PubMed:23028956}.
CC   -!- DEVELOPMENTAL STAGE: During adipocyte differentiation, levels are
CC       elevated two-fold (at protein level). {ECO:0000269|PubMed:23028956}.
CC   -!- DOMAIN: The PH domain binds phosphoinositides.
CC       {ECO:0000269|PubMed:20599956}.
CC   -!- SIMILARITY: Belongs to the OSBP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF392454; AAL40667.1; -; mRNA.
DR   EMBL; AK292702; BAF85391.1; -; mRNA.
DR   EMBL; CH471052; EAW79389.1; -; Genomic_DNA.
DR   EMBL; BC065213; AAH65213.1; -; mRNA.
DR   EMBL; AF346292; AAK31141.1; -; mRNA.
DR   CCDS; CCDS3033.1; -.
DR   RefSeq; NP_073613.2; NM_022776.4.
DR   PDB; 2D9X; NMR; -; A=59-165.
DR   PDBsum; 2D9X; -.
DR   BMRB; Q9BXB4; -.
DR   SMR; Q9BXB4; -.
DR   BioGRID; 125386; 36.
DR   IntAct; Q9BXB4; 14.
DR   STRING; 9606.ENSP00000296220; -.
DR   iPTMnet; Q9BXB4; -.
DR   PhosphoSitePlus; Q9BXB4; -.
DR   BioMuta; OSBPL11; -.
DR   DMDM; 20139127; -.
DR   EPD; Q9BXB4; -.
DR   jPOST; Q9BXB4; -.
DR   MassIVE; Q9BXB4; -.
DR   MaxQB; Q9BXB4; -.
DR   PaxDb; Q9BXB4; -.
DR   PeptideAtlas; Q9BXB4; -.
DR   PRIDE; Q9BXB4; -.
DR   ProteomicsDB; 79398; -.
DR   Antibodypedia; 33023; 272 antibodies.
DR   DNASU; 114885; -.
DR   Ensembl; ENST00000296220; ENSP00000296220; ENSG00000144909.
DR   GeneID; 114885; -.
DR   KEGG; hsa:114885; -.
DR   UCSC; uc003eic.4; human.
DR   CTD; 114885; -.
DR   DisGeNET; 114885; -.
DR   GeneCards; OSBPL11; -.
DR   HGNC; HGNC:16397; OSBPL11.
DR   HPA; ENSG00000144909; Tissue enhanced (skeletal).
DR   MIM; 606739; gene.
DR   neXtProt; NX_Q9BXB4; -.
DR   OpenTargets; ENSG00000144909; -.
DR   PharmGKB; PA32825; -.
DR   VEuPathDB; HostDB:ENSG00000144909.7; -.
DR   eggNOG; KOG2210; Eukaryota.
DR   GeneTree; ENSGT00940000158398; -.
DR   HOGENOM; CLU_012334_3_1_1; -.
DR   InParanoid; Q9BXB4; -.
DR   OMA; QGVTNHA; -.
DR   OrthoDB; 949920at2759; -.
DR   PhylomeDB; Q9BXB4; -.
DR   TreeFam; TF312807; -.
DR   PathwayCommons; Q9BXB4; -.
DR   BioGRID-ORCS; 114885; 7 hits in 874 CRISPR screens.
DR   ChiTaRS; OSBPL11; human.
DR   EvolutionaryTrace; Q9BXB4; -.
DR   GeneWiki; OSBPL11; -.
DR   GenomeRNAi; 114885; -.
DR   Pharos; Q9BXB4; Tbio.
DR   PRO; PR:Q9BXB4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9BXB4; protein.
DR   Bgee; ENSG00000144909; Expressed in gastrocnemius and 235 other tissues.
DR   ExpressionAtlas; Q9BXB4; baseline and differential.
DR   Genevisible; Q9BXB4; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0008289; F:lipid binding; IBA:GO_Central.
DR   GO; GO:0032934; F:sterol binding; IBA:GO_Central.
DR   GO; GO:0015248; F:sterol transporter activity; IBA:GO_Central.
DR   GO; GO:0045444; P:fat cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0010890; P:positive regulation of sequestering of triglyceride; IMP:BHF-UCL.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037239; OSBP_sf.
DR   InterPro; IPR000648; Oxysterol-bd.
DR   InterPro; IPR018494; Oxysterol-bd_CS.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR10972; PTHR10972; 1.
DR   Pfam; PF01237; Oxysterol_BP; 1.
DR   Pfam; PF00169; PH; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF144000; SSF144000; 1.
DR   PROSITE; PS01013; OSBP; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Endosome; Golgi apparatus; Lipid transport;
KW   Lipid-binding; Membrane; Phosphoprotein; Reference proteome; Transport.
FT   CHAIN           1..747
FT                   /note="Oxysterol-binding protein-related protein 11"
FT                   /id="PRO_0000100381"
FT   DOMAIN          58..155
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         27
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         62
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         172
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         177
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CI95"
FT   MOD_RES         181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         184
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   VARIANT         184
FT                   /note="S -> L (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs746035150)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036100"
FT   STRAND          62..70
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   TURN            71..73
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          74..82
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   TURN            84..86
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          88..94
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   HELIX           95..97
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          98..100
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          103..107
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          117..121
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          123..125
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          128..130
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   STRAND          133..135
FT                   /evidence="ECO:0000244|PDB:2D9X"
FT   HELIX           140..160
FT                   /evidence="ECO:0000244|PDB:2D9X"
SQ   SEQUENCE   747 AA;  83643 MW;  B443D3BDE8AE5FB6 CRC64;
     MQGGEPVSTM KVSESEGKLE GQATAVTPNK NSSCGGGISS SSSSRGGSAK GWQYSDHMEN
     VYGYLMKYTN LVTGWQYRFF VLNNEAGLLE YFVNEQSRNQ KPRGTLQLAG AVISPSDEDS
     HTFTVNAASG EQYKLRATDA KERQHWVSRL QICTQHHTEA IGKNNPPLKS RSFSLASSSN
     SPISQRRPSQ NAISFFNVGH SKLQSLSKRT NLPPDHLVEV REMMSHAEGQ QRDLIRRIEC
     LPTSGHLSSL DQDLLMLKAT SMATMNCLND CFHILQLQHA SHQKGSLPSG TTIEWLEPKI
     SLSNHYKNGA DQPFATDQSK PVAVPEEQPV AESGLLAREP EEINADDEIE DTCDHKEDDL
     GAVEEQRSVI LHLLSQLKLG MDLTRVVLPT FILEKRSLLE MYADFMSHPD LFIAITNGAT
     AEDRMIRFVE YYLTSFHEGR KGAIAKKPYN PIIGETFHCS WKMPKSEVAS SVFSSSSTQG
     VTNHAPLSGE SLTQVGSDCY TVRFVAEQVS HHPPVSGFYA ECTERKMCVN AHVWTKSKFL
     GMSIGVTMVG EGILSLLEHG EEYTFSLPCA YARSILTVPW VELGGKVSVN CAKTGYSASI
     TFHTKPFYGG KLHRVTAEVK HNITNTVVCR VQGEWNSVLE FTYSNGETKY VDLTKLAVTK
     KRVRPLEKQD PFESRRLWKN VTDSLRESEI DKATEHKHTL EERQRTEERH RTETGTPWKT
     KYFIKEGDGW VYHKPLWKII PTTQPAE
//
ID   OSGI1_HUMAN             Reviewed;         477 AA.
AC   Q9UJX0; Q52M33; Q86UQ1; Q96S88; Q9BZ70;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   03-JUL-2019, sequence version 4.
DT   10-FEB-2021, entry version 146.
DE   RecName: Full=Oxidative stress-induced growth inhibitor 1 {ECO:0000305};
DE   AltName: Full=Bone marrow stromal cell-derived growth inhibitor {ECO:0000303|PubMed:15569677};
DE            Short=BMSC-derived growth inhibitor {ECO:0000303|PubMed:15569677};
DE   AltName: Full=Ovary, kidney and liver protein 38;
DE            Short=huOKL38;
DE   AltName: Full=Pregnancy-induced growth inhibitor OKL38 {ECO:0000305|PubMed:15569677};
GN   Name=OSGIN1 {ECO:0000312|HGNC:HGNC:30093};
GN   Synonyms=BDGI {ECO:0000303|PubMed:15569677},
GN   OKL38 {ECO:0000303|PubMed:14570898};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=14570898; DOI=10.1074/jbc.m308668200;
RA   Ong C.K., Ng C.Y., Leong C., Ng C.P., Foo K.T., Tan P.H., Huynh H.T.;
RT   "Genomic structure of human OKL38 gene and its differential expression in
RT   kidney carcinogenesis.";
RL   J. Biol. Chem. 279:743-754(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=15569677; DOI=10.1074/jbc.m408708200;
RA   Wang T., Xia D., Li N., Wang C., Chen T., Wan T., Chen G., Cao X.;
RT   "Bone marrow stromal cell-derived growth inhibitor inhibits growth and
RT   migration of breast cancer cells via induction of cell cycle arrest and
RT   apoptosis.";
RL   J. Biol. Chem. 280:4374-4382(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Leukocyte, and Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 62-477, FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary gland, and Ovary;
RX   PubMed=11459809; DOI=10.1210/endo.142.8.8297;
RA   Huynh H.T., Ng C.Y., Ong C.K., Lim K.B., Chan T.W.M.;
RT   "Cloning and characterization of a novel pregnancy-induced growth inhibitor
RT   in mammary gland.";
RL   Endocrinology 142:3607-3615(2001).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Regulates the differentiation and proliferation through the
CC       regulation of cell death. {ECO:0000269|PubMed:11459809,
CC       ECO:0000269|PubMed:14570898, ECO:0000269|PubMed:15569677}.
CC   -!- INTERACTION:
CC       Q9UJX0; A0A087WVE9: ARNT2; NbExp=3; IntAct=EBI-9057006, EBI-12808086;
CC       Q9UJX0; O75815: BCAR3; NbExp=4; IntAct=EBI-9057006, EBI-702336;
CC       Q9UJX0; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-9057006, EBI-10181188;
CC       Q9UJX0; Q9BX70: BTBD2; NbExp=3; IntAct=EBI-9057006, EBI-710091;
CC       Q9UJX0; P20807: CAPN3; NbExp=4; IntAct=EBI-9057006, EBI-5655000;
CC       Q9UJX0; Q96H22-3: CENPN; NbExp=3; IntAct=EBI-9057006, EBI-19948078;
CC       Q9UJX0; O43186: CRX; NbExp=3; IntAct=EBI-9057006, EBI-748171;
CC       Q9UJX0; Q9NUI1: DECR2; NbExp=3; IntAct=EBI-9057006, EBI-3937367;
CC       Q9UJX0; Q96EY1-2: DNAJA3; NbExp=3; IntAct=EBI-9057006, EBI-3952284;
CC       Q9UJX0; P48507: GCLM; NbExp=3; IntAct=EBI-9057006, EBI-1051387;
CC       Q9UJX0; Q9Y6K9: IKBKG; NbExp=3; IntAct=EBI-9057006, EBI-81279;
CC       Q9UJX0; Q9UKT9: IKZF3; NbExp=5; IntAct=EBI-9057006, EBI-747204;
CC       Q9UJX0; Q0VD86: INCA1; NbExp=6; IntAct=EBI-9057006, EBI-6509505;
CC       Q9UJX0; Q9H079: KATNBL1; NbExp=3; IntAct=EBI-9057006, EBI-715394;
CC       Q9UJX0; O95678: KRT75; NbExp=3; IntAct=EBI-9057006, EBI-2949715;
CC       Q9UJX0; Q8TBB1: LNX1; NbExp=6; IntAct=EBI-9057006, EBI-739832;
CC       Q9UJX0; A8MW99: MEI4; NbExp=3; IntAct=EBI-9057006, EBI-19944212;
CC       Q9UJX0; O14770: MEIS2; NbExp=4; IntAct=EBI-9057006, EBI-2804934;
CC       Q9UJX0; P50221: MEOX1; NbExp=3; IntAct=EBI-9057006, EBI-2864512;
CC       Q9UJX0; P50222: MEOX2; NbExp=3; IntAct=EBI-9057006, EBI-748397;
CC       Q9UJX0; Q7Z6M4: MTERF4; NbExp=5; IntAct=EBI-9057006, EBI-948435;
CC       Q9UJX0; Q02548: PAX5; NbExp=3; IntAct=EBI-9057006, EBI-296331;
CC       Q9UJX0; P27815-4: PDE4A; NbExp=3; IntAct=EBI-9057006, EBI-12080840;
CC       Q9UJX0; Q08493-2: PDE4C; NbExp=3; IntAct=EBI-9057006, EBI-12169289;
CC       Q9UJX0; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-9057006, EBI-79165;
CC       Q9UJX0; Q8WUT1: POLDIP3; NbExp=3; IntAct=EBI-9057006, EBI-10276663;
CC       Q9UJX0; P62487: POLR2G; NbExp=3; IntAct=EBI-9057006, EBI-347928;
CC       Q9UJX0; Q04864: REL; NbExp=3; IntAct=EBI-9057006, EBI-307352;
CC       Q9UJX0; Q04864-2: REL; NbExp=3; IntAct=EBI-9057006, EBI-10829018;
CC       Q9UJX0; Q8IYX7: SAXO1; NbExp=3; IntAct=EBI-9057006, EBI-3957636;
CC       Q9UJX0; O60504: SORBS3; NbExp=3; IntAct=EBI-9057006, EBI-741237;
CC       Q9UJX0; Q99081: TCF12; NbExp=4; IntAct=EBI-9057006, EBI-722877;
CC       Q9UJX0; P15884: TCF4; NbExp=4; IntAct=EBI-9057006, EBI-533224;
CC       Q9UJX0; Q08117: TLE5; NbExp=3; IntAct=EBI-9057006, EBI-717810;
CC       Q9UJX0; Q08117-2: TLE5; NbExp=3; IntAct=EBI-9057006, EBI-11741437;
CC       Q9UJX0; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-9057006, EBI-2130429;
CC       Q9UJX0; B2RXF5: ZBTB42; NbExp=3; IntAct=EBI-9057006, EBI-12287587;
CC       Q9UJX0; Q53FD0-2: ZC2HC1C; NbExp=3; IntAct=EBI-9057006, EBI-14104088;
CC       Q9UJX0; Q969J2: ZKSCAN4; NbExp=3; IntAct=EBI-9057006, EBI-2818641;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest expression in the ovary,
CC       testis, kidney, skeletal muscle and liver (PubMed:11459809,
CC       PubMed:14570898, PubMed:15569677). Weakly expressed in spleen, heart,
CC       kidney, and pancreas (PubMed:15569677). Highly expressed in tumor cells
CC       (at protein level) (PubMed:15569677). {ECO:0000269|PubMed:11459809,
CC       ECO:0000269|PubMed:14570898, ECO:0000269|PubMed:15569677}.
CC   -!- INDUCTION: By pregnancy.
CC   -!- MISCELLANEOUS: Loss of OSGIN1 protein disturbs the balance between cell
CC       growth, differentiation, and cell death in normal tissue, resulting in
CC       uncontrolled growth and formation of tumors.
CC   -!- SIMILARITY: Belongs to the OKL38 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF06662.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAF06662.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAK01722.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAP14662.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF334780; AAK01722.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; AY258066; AAP14662.1; ALT_SEQ; mRNA.
DR   EMBL; AY258067; AAP14663.1; -; mRNA.
DR   EMBL; AY258068; AAP14664.1; -; mRNA.
DR   EMBL; AY037158; AAK67637.1; -; mRNA.
DR   EMBL; AK290383; BAF83072.1; -; mRNA.
DR   EMBL; AC040169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471114; EAW95511.1; -; Genomic_DNA.
DR   EMBL; BC093687; AAH93687.2; -; mRNA.
DR   EMBL; BC113417; AAI13418.2; -; mRNA.
DR   EMBL; BC032476; AAH32476.1; -; mRNA.
DR   EMBL; AF191740; AAF06662.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS10939.1; -.
DR   RefSeq; NP_892026.1; NM_182981.2.
DR   BioGRID; 118985; 51.
DR   IntAct; Q9UJX0; 46.
DR   MINT; Q9UJX0; -.
DR   STRING; 9606.ENSP00000355374; -.
DR   iPTMnet; Q9UJX0; -.
DR   PhosphoSitePlus; Q9UJX0; -.
DR   BioMuta; OSGIN1; -.
DR   DMDM; 334302887; -.
DR   CPTAC; CPTAC-1212; -.
DR   MassIVE; Q9UJX0; -.
DR   PaxDb; Q9UJX0; -.
DR   PeptideAtlas; Q9UJX0; -.
DR   PRIDE; Q9UJX0; -.
DR   Antibodypedia; 16990; 131 antibodies.
DR   DNASU; 29948; -.
DR   Ensembl; ENST00000361711; ENSP00000355374; ENSG00000140961.
DR   Ensembl; ENST00000393306; ENSP00000376983; ENSG00000140961.
DR   GeneID; 29948; -.
DR   KEGG; hsa:29948; -.
DR   UCSC; uc002fha.4; human.
DR   CTD; 29948; -.
DR   DisGeNET; 29948; -.
DR   GeneCards; OSGIN1; -.
DR   HGNC; HGNC:30093; OSGIN1.
DR   HPA; ENSG00000140961; Tissue enhanced (liver).
DR   MIM; 607975; gene.
DR   neXtProt; NX_Q9UJX0; -.
DR   OpenTargets; ENSG00000140961; -.
DR   PharmGKB; PA162398489; -.
DR   VEuPathDB; HostDB:ENSG00000140961.12; -.
DR   eggNOG; ENOG502QRUQ; Eukaryota.
DR   GeneTree; ENSGT00390000006658; -.
DR   HOGENOM; CLU_019308_2_0_1; -.
DR   InParanoid; Q9UJX0; -.
DR   OrthoDB; 890629at2759; -.
DR   PhylomeDB; Q9UJX0; -.
DR   TreeFam; TF313502; -.
DR   PathwayCommons; Q9UJX0; -.
DR   BioGRID-ORCS; 29948; 9 hits in 869 CRISPR screens.
DR   ChiTaRS; OSGIN1; human.
DR   GenomeRNAi; 29948; -.
DR   Pharos; Q9UJX0; Tbio.
DR   PRO; PR:Q9UJX0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q9UJX0; protein.
DR   Bgee; ENSG00000140961; Expressed in right lobe of liver and 186 other tissues.
DR   ExpressionAtlas; Q9UJX0; baseline and differential.
DR   Genevisible; Q9UJX0; HS.
DR   GO; GO:0008083; F:growth factor activity; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:InterPro.
DR   GO; GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IMP:UniProtKB.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR029731; OKL38_fam.
DR   InterPro; IPR029724; OSGIN1.
DR   PANTHER; PTHR15192; PTHR15192; 1.
DR   PANTHER; PTHR15192:SF15; PTHR15192:SF15; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
PE   1: Evidence at protein level;
KW   Developmental protein; Differentiation; Growth regulation; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..477
FT                   /note="Oxidative stress-induced growth inhibitor 1"
FT                   /id="PRO_0000165371"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   VARIANT         356
FT                   /note="E -> D (in dbSNP:rs35145453)"
FT                   /id="VAR_056575"
SQ   SEQUENCE   477 AA;  51992 MW;  29E936C20B23E7C0 CRC64;
     MSSSRKDHLG ASSSEPLPVI IVGNGPSGIC LSYLLSGYTP YTKPDAIHPH PLLQRKLTEA
     PGVSILDQDL DYLSEGLEGR SQSPVALLFD ALLRPDTDFG GNMKSVLTWK HRKEHAIPHV
     VLGRNLPGGA WHSIEGSMVI LSQGQWMGLP DLEVKDWMQK KRRGLRNSRA TAGDIAHYYR
     DYVVKKGLGH NFVSGAVVTA VEWGTPDPSS CGAQDSSPLF QVSGFLTRNQ AQQPFSLWAR
     NVVLATGTFD SPARLGIPGE ALPFIHHELS ALEAATRVGA VTPASDPVLI IGAGLSAADA
     VLYARHYNIP VIHAFRRAVD DPGLVFNQLP KMLYPEYHKV HQMMREQSIL SPSPYEGYRS
     LPRHQLLCFK EDCQAVFQDL EGVEKVFGVS LVLVLIGSHP DLSFLPGAGA DFAVDPDQPL
     SAKRNPIDVD PFTYQSTRQE GLYAMGPLAG DNFVRFVQGG ALAVASSLLR KETRKPP
//
ID   PIGS_HUMAN              Reviewed;         555 AA.
AC   Q96S52; Q6UVX6;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-FEB-2021, entry version 148.
DE   RecName: Full=GPI transamidase component PIG-S;
DE   AltName: Full=Phosphatidylinositol-glycan biosynthesis class S protein;
GN   Name=PIGS; ORFNames=UNQ1873/PRO4316;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 2-21, FUNCTION,
RP   SUBUNIT, SUBCELLULAR LOCATION, AND MEMBRANE TOPOLOGY.
RX   PubMed=11483512; DOI=10.1093/emboj/20.15.4088;
RA   Ohishi K., Inoue N., Kinoshita T.;
RT   "PIG-S and PIG-T, essential for GPI anchor attachment to proteins, form a
RT   complex with GAA1 and GPI8.";
RL   EMBO J. 20:4088-4098(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [6]
RP   INVOLVEMENT IN GPIBD18, VARIANTS GPIBD18 PRO-34; 36-TRP--ASP-555 DEL;
RP   GLY-308 AND 439-THR--LYS-451 DELINS ARG-LEU-LEU, PATHWAY, AND FUNCTION.
RX   PubMed=30269814; DOI=10.1016/j.ajhg.2018.08.014;
RA   Nguyen T.T.M., Murakami Y., Wigby K.M., Baratang N.V., Rousseau J.,
RA   St-Denis A., Rosenfeld J.A., Laniewski S.C., Jones J., Iglesias A.D.,
RA   Jones M.C., Masser-Frye D., Scheuerle A.E., Perry D.L., Taft R.J.,
RA   Le Deist F., Thompson M., Kinoshita T., Campeau P.M.;
RT   "Mutations in PIGS, encoding a GPI transamidase, cause a neurological
RT   syndrome ranging from fetal akinesia to epileptic encephalopathy.";
RL   Am. J. Hum. Genet. 103:602-611(2018).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-159.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Component of the GPI transamidase complex. Essential for
CC       transfer of GPI to proteins, particularly for formation of carbonyl
CC       intermediates. {ECO:0000269|PubMed:11483512,
CC       ECO:0000269|PubMed:30269814}.
CC   -!- PATHWAY: Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor
CC       biosynthesis. {ECO:0000269|PubMed:30269814}.
CC   -!- SUBUNIT: Forms a complex with PIGK/GPI8, PIGT, PIGU and GAA1.
CC       {ECO:0000269|PubMed:11483512}.
CC   -!- INTERACTION:
CC       Q96S52; Q6A162: KRT40; NbExp=3; IntAct=EBI-2908273, EBI-10171697;
CC       Q96S52; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-2908273, EBI-10171774;
CC       Q96S52; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-2908273, EBI-10172052;
CC       Q96S52; Q3LHN2: KRTAP19-2; NbExp=3; IntAct=EBI-2908273, EBI-12196745;
CC       Q96S52; Q9BYR9: KRTAP2-4; NbExp=3; IntAct=EBI-2908273, EBI-14065470;
CC       Q96S52; Q9BYQ4: KRTAP9-2; NbExp=3; IntAct=EBI-2908273, EBI-1044640;
CC       Q96S52; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-2908273, EBI-945833;
CC       Q96S52; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-2908273, EBI-22310682;
CC       Q96S52; Q15654: TRIP6; NbExp=3; IntAct=EBI-2908273, EBI-742327;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11483512}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11483512}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96S52-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96S52-2; Sequence=VSP_013158;
CC   -!- DISEASE: Glycosylphosphatidylinositol biosynthesis defect 18 (GPIBD18)
CC       [MIM:618143]: An autosomal recessive disorder with onset in utero or
CC       early infancy and characterized by severe global developmental delay,
CC       seizures, hypotonia, weakness, ataxia, and dysmorphic facial features.
CC       {ECO:0000269|PubMed:30269814}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PIGS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB057723; BAB60853.1; -; mRNA.
DR   EMBL; AY359112; AAQ89470.1; -; mRNA.
DR   EMBL; BC069228; AAH69228.1; -; mRNA.
DR   CCDS; CCDS11235.1; -. [Q96S52-1]
DR   RefSeq; NP_149975.1; NM_033198.3. [Q96S52-1]
DR   BioGRID; 125082; 73.
DR   CORUM; Q96S52; -.
DR   IntAct; Q96S52; 41.
DR   MINT; Q96S52; -.
DR   STRING; 9606.ENSP00000309430; -.
DR   GlyConnect; 1285; 1 N-Linked glycan (1 site).
DR   GlyGen; Q96S52; 2 sites.
DR   iPTMnet; Q96S52; -.
DR   PhosphoSitePlus; Q96S52; -.
DR   BioMuta; PIGS; -.
DR   DMDM; 21759353; -.
DR   EPD; Q96S52; -.
DR   jPOST; Q96S52; -.
DR   MassIVE; Q96S52; -.
DR   MaxQB; Q96S52; -.
DR   PaxDb; Q96S52; -.
DR   PeptideAtlas; Q96S52; -.
DR   PRIDE; Q96S52; -.
DR   ProteomicsDB; 78065; -. [Q96S52-1]
DR   ProteomicsDB; 78066; -. [Q96S52-2]
DR   Antibodypedia; 2984; 112 antibodies.
DR   Ensembl; ENST00000308360; ENSP00000309430; ENSG00000087111. [Q96S52-1]
DR   Ensembl; ENST00000395346; ENSP00000378755; ENSG00000087111. [Q96S52-2]
DR   GeneID; 94005; -.
DR   KEGG; hsa:94005; -.
DR   UCSC; uc002hbn.3; human. [Q96S52-1]
DR   CTD; 94005; -.
DR   DisGeNET; 94005; -.
DR   GeneCards; PIGS; -.
DR   HGNC; HGNC:14937; PIGS.
DR   HPA; ENSG00000087111; Low tissue specificity.
DR   MalaCards; PIGS; -.
DR   MIM; 610271; gene.
DR   MIM; 618143; phenotype.
DR   neXtProt; NX_Q96S52; -.
DR   OpenTargets; ENSG00000087111; -.
DR   PharmGKB; PA33301; -.
DR   VEuPathDB; HostDB:ENSG00000087111.20; -.
DR   eggNOG; KOG2459; Eukaryota.
DR   GeneTree; ENSGT00390000017203; -.
DR   HOGENOM; CLU_010026_3_0_1; -.
DR   InParanoid; Q96S52; -.
DR   OMA; FVNAAEW; -.
DR   PhylomeDB; Q96S52; -.
DR   TreeFam; TF105857; -.
DR   PathwayCommons; Q96S52; -.
DR   Reactome; R-HSA-162791; Attachment of GPI anchor to uPAR.
DR   SIGNOR; Q96S52; -.
DR   UniPathway; UPA00196; -.
DR   BioGRID-ORCS; 94005; 73 hits in 876 CRISPR screens.
DR   ChiTaRS; PIGS; human.
DR   GeneWiki; PIGS_(gene); -.
DR   GenomeRNAi; 94005; -.
DR   Pharos; Q96S52; Tdark.
DR   PRO; PR:Q96S52; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q96S52; protein.
DR   Bgee; ENSG00000087111; Expressed in heart left ventricle and 118 other tissues.
DR   ExpressionAtlas; Q96S52; baseline and differential.
DR   Genevisible; Q96S52; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0042765; C:GPI-anchor transamidase complex; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016255; P:attachment of GPI anchor to protein; TAS:UniProtKB.
DR   InterPro; IPR019540; PtdIno-glycan_biosynth_class_S.
DR   PANTHER; PTHR21072; PTHR21072; 1.
DR   Pfam; PF10510; PIG-S; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Disease variant;
KW   Endoplasmic reticulum; Epilepsy; Glycoprotein; GPI-anchor biosynthesis;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:11483512"
FT   CHAIN           2..555
FT                   /note="GPI transamidase component PIG-S"
FT                   /id="PRO_0000218604"
FT   TOPO_DOM        2..18
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        19..39
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        40..520
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        521..541
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        542..555
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        267
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        370
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..11
FT                   /note="MAAAGAAATHL -> MPS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_013158"
FT   VARIANT         34
FT                   /note="L -> P (in GPIBD18; partial loss of function; when
FT                   tested in PIGS-knockout cells, mediates partial restoration
FT                   of GPI-anchored protein expression at the cell surface;
FT                   dbSNP:rs1567618413)"
FT                   /evidence="ECO:0000269|PubMed:30269814"
FT                   /id="VAR_081579"
FT   VARIANT         36..555
FT                   /note="Missing (in GPIBD18; almost complete loss of
FT                   function; when tested in PIGS-knockout cells, mediates only
FT                   very partial restoration of GPI-anchored protein expression
FT                   at the cell surface; strong decrease in protein level,
FT                   possibly due to nonsense-mediated mRNA decay)"
FT                   /evidence="ECO:0000269|PubMed:30269814"
FT                   /id="VAR_081580"
FT   VARIANT         159
FT                   /note="M -> I (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036510"
FT   VARIANT         253
FT                   /note="R -> H (in dbSNP:rs34669811)"
FT                   /id="VAR_053582"
FT   VARIANT         308
FT                   /note="E -> G (in GPIBD18; dbSNP:rs1426262136)"
FT                   /evidence="ECO:0000269|PubMed:30269814"
FT                   /id="VAR_081581"
FT   VARIANT         439..451
FT                   /note="TTTLTSLAQLLGK -> RLL (in GPIBD18; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:30269814"
FT                   /id="VAR_081582"
SQ   SEQUENCE   555 AA;  61656 MW;  A20B323C5475EF4F CRC64;
     MAAAGAAATH LEVARGKRAA LFFAAVAIVL GLPLWWKTTE TYRASLPYSQ ISGLNALQLR
     LMVPVTVVFT RESVPLDDQE KLPFTVVHER EIPLKYKMKI KCRFQKAYRR ALDHEEEALS
     SGSVQEAEAM LDEPQEQAEG SLTVYVISEH SSLLPQDMMS YIGPKRTAVV RGIMHREAFN
     IIGRRIVQVA QAMSLTEDVL AAALADHLPE DKWSAEKRRP LKSSLGYEIT FSLLNPDPKS
     HDVYWDIEGA VRRYVQPFLN ALGAAGNFSV DSQILYYAML GVNPRFDSAS SSYYLDMHSL
     PHVINPVESR LGSSAASLYP VLNFLLYVPE LAHSPLYIQD KDGAPVATNA FHSPRWGGIM
     VYNVDSKTYN ASVLPVRVEV DMVRVMEVFL AQLRLLFGIA QPQLPPKCLL SGPTSEGLMT
     WELDRLLWAR SVENLATATT TLTSLAQLLG KISNIVIKDD VASEVYKAVA AVQKSAEELA
     SGHLASAFVA SQEAVTSSEL AFFDPSLLHL LYFPDDQKFA IYIPLFLPMA VPILLSLVKI
     FLETRKSWRK PEKTD
//
ID   PPA5_HUMAN              Reviewed;         325 AA.
AC   P13686; A8K3V2; Q2TAB1; Q6IAS6; Q9UCJ5; Q9UCJ6; Q9UCJ7;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 3.
DT   10-FEB-2021, entry version 200.
DE   RecName: Full=Tartrate-resistant acid phosphatase type 5;
DE            Short=TR-AP;
DE            EC=3.1.3.2;
DE   AltName: Full=Tartrate-resistant acid ATPase;
DE            Short=TrATPase;
DE   AltName: Full=Type 5 acid phosphatase;
DE   Flags: Precursor;
GN   Name=ACP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2909539;
RA   Ketcham C.M., Roberts R.M., Simmen R.C.M., Nick H.S.;
RT   "Molecular cloning of the type 5, iron-containing, tartrate-resistant acid
RT   phosphatase from human placenta.";
RL   J. Biol. Chem. 264:557-563(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2338077; DOI=10.1111/j.1432-1033.1990.tb15488.x;
RA   Lord D.K., Cross N.C.P., Bevilacqua M.A., Roder S.H., Gorman P.A.,
RA   Groves A.V., Moss D.W., Sheer D., Cox T.M.;
RT   "Type 5 acid phosphatase. Sequence, expression and chromosomal localization
RT   of a differentiation-associated protein of the human macrophage.";
RL   Eur. J. Biochem. 189:287-293(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS MET-148 AND MET-200.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-245.
RX   PubMed=8359686; DOI=10.1016/0378-1119(93)90420-8;
RA   Cassady A.I., King A.G., Cross N.C.P., Hume D.A.;
RT   "Isolation and characterization of the genes encoding mouse and human type-
RT   5 acid phosphatase.";
RL   Gene 130:201-207(1993).
RN   [7]
RP   PROTEIN SEQUENCE OF 22-64 AND 183-202.
RC   TISSUE=Osteoclastoma;
RX   PubMed=2775236; DOI=10.1042/bj2610601;
RA   Hayman A.R., Warburton M.J., Pringle J.A.S., Coles B., Chambers T.J.;
RT   "Purification and characterization of a tartrate-resistant acid phosphatase
RT   from human osteoclastomas.";
RL   Biochem. J. 261:601-609(1989).
RN   [8]
RP   PROTEIN SEQUENCE OF 22-55 AND 183-203, AND SUBUNIT.
RC   TISSUE=Spleen;
RX   PubMed=1477968; DOI=10.1016/0009-9120(92)90075-4;
RA   Janckila A.J., Latham M.D., Lam K.-W., Chow K.-C., Li C.-Y., Yam L.T.;
RT   "Heterogeneity of hairy cell tartrate-resistant acid phosphatase.";
RL   Clin. Biochem. 25:437-443(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 22-37.
RC   TISSUE=Osteoclastoma;
RX   PubMed=2610679; DOI=10.1016/0006-291x(89)92705-8;
RA   Stepan J.J., Lau K.H.W., Mohan S., Kraenzlin M., Baylink D.J.;
RT   "Purification and N-terminal sequence of two tartrate-resistant acid
RT   phosphatases type-5 from the hairy cell leukemia spleen.";
RL   Biochem. Biophys. Res. Commun. 165:1027-1034(1989).
RN   [10]
RP   PROTEIN SEQUENCE OF 22-31.
RC   TISSUE=Osteoclastoma;
RX   PubMed=2334436; DOI=10.1016/0006-291x(90)92391-c;
RA   Stepan J.J., Lau K.H.W., Mohan S., Singer F.R., Baylink D.J.;
RT   "Purification and N-terminal amino acid sequence of the tartrate-resistant
RT   acid phosphatase from human osteoclastoma: evidence for a single
RT   structure.";
RL   Biochem. Biophys. Res. Commun. 168:792-800(1990).
RN   [11]
RP   SUBUNIT.
RX   PubMed=1872798; DOI=10.1042/bj2770631;
RA   Hayman A.R., Dryden A.J., Chambers T.J., Warburton M.J.;
RT   "Tartrate-resistant acid phosphatase from human osteoclastomas is
RT   translated as a single polypeptide.";
RL   Biochem. J. 277:631-634(1991).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 22-325 IN COMPLEX WITH IRON IONS,
RP   AND GLYCOSYLATION AT ASN-116.
RX   PubMed=15993892; DOI=10.1016/j.jmb.2005.04.014;
RA   Straeter N., Jasper B., Scholte M., Krebs B., Duff A.P., Langley D.B.,
RA   Han R., Averill B.A., Freeman H.C., Guss J.M.;
RT   "Crystal structures of recombinant human purple acid phosphatase with and
RT   without an inhibitory conformation of the repression loop.";
RL   J. Mol. Biol. 351:233-246(2005).
RN   [13]
RP   VARIANTS SPENCDI ILE-89; ARG-215; ASN-241 AND LYS-264.
RX   PubMed=21217755; DOI=10.1038/ng.748;
RA   Briggs T.A., Rice G.I., Daly S., Urquhart J., Gornall H., Bader-Meunier B.,
RA   Baskar K., Baskar S., Baudouin V., Beresford M.W., Black G.C.,
RA   Dearman R.J., de Zegher F., Foster E.S., Frances C., Hayman A.R.,
RA   Hilton E., Job-Deslandre C., Kulkarni M.L., Le Merrer M., Linglart A.,
RA   Lovell S.C., Maurer K., Musset L., Navarro V., Picard C., Puel A.,
RA   Rieux-Laucat F., Roifman C.M., Scholl-Burgi S., Smith N., Szynkiewicz M.,
RA   Wiedeman A., Wouters C., Zeef L.A., Casanova J.L., Elkon K.B., Janckila A.,
RA   Lebon P., Crow Y.J.;
RT   "Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia
RT   with autoimmunity and a type I interferon expression signature.";
RL   Nat. Genet. 43:127-131(2011).
RN   [14]
RP   VARIANTS SPENCDI MET-52; ARG-109; PRO-201; ARG-215; HIS-262; LYS-264 AND
RP   TYR-278 DEL.
RX   PubMed=21217752; DOI=10.1038/ng.749;
RA   Lausch E., Janecke A., Bros M., Trojandt S., Alanay Y., De Laet C.,
RA   Hubner C.A., Meinecke P., Nishimura G., Matsuo M., Hirano Y.,
RA   Tenoutasse S., Kiss A., Rosa R.F., Unger S.L., Renella R., Bonafe L.,
RA   Spranger J., Unger S., Zabel B., Superti-Furga A.;
RT   "Genetic deficiency of tartrate-resistant acid phosphatase associated with
RT   skeletal dysplasia, cerebral calcifications and autoimmunity.";
RL   Nat. Genet. 43:132-137(2011).
CC   -!- FUNCTION: Involved in osteopontin/bone sialoprotein dephosphorylation.
CC       Its expression seems to increase in certain pathological states such as
CC       Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-
CC       cell leukemias.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a phosphate monoester + H2O = an alcohol + phosphate;
CC         Xref=Rhea:RHEA:15017, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:67140; EC=3.1.3.2;
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC       Note=Binds 2 iron ions per subunit.;
CC   -!- SUBUNIT: Exists either as monomer or, after proteolytic processing, as
CC       a dimer of two chains linked by disulfide bond(s).
CC       {ECO:0000269|PubMed:1477968, ECO:0000269|PubMed:15993892,
CC       ECO:0000269|PubMed:1872798}.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- DISEASE: Spondyloenchondrodysplasia with immune dysregulation (SPENCDI)
CC       [MIM:607944]: A disease characterized by vertebral and metaphyseal
CC       dysplasia, spasticity with cerebral calcifications, and strong
CC       predisposition to autoimmune diseases. The skeletal dysplasia is
CC       characterized by radiolucent and irregular spondylar and metaphyseal
CC       lesions that represent islands of chondroid tissue within bone.
CC       {ECO:0000269|PubMed:21217752, ECO:0000269|PubMed:21217755}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry. ACP5 inactivating mutations result in a functional excess of
CC       phosphorylated osteopontin causing deregulation of osteopontin
CC       signaling and consequential autoimmune disease.
CC   -!- SIMILARITY: Belongs to the metallophosphoesterase superfamily. Purple
CC       acid phosphatase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Tartrate-resistant acid phosphatase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Tartrate-resistant_acid_phosphatase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04430; AAA76849.1; -; mRNA.
DR   EMBL; X14618; CAA32771.1; -; mRNA.
DR   EMBL; CR457078; CAG33359.1; -; mRNA.
DR   EMBL; AK290717; BAF83406.1; -; mRNA.
DR   EMBL; BC025414; AAH25414.1; -; mRNA.
DR   EMBL; BC111014; AAI11015.1; -; mRNA.
DR   EMBL; X67123; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS12265.1; -.
DR   PIR; S15752; S15752.
DR   RefSeq; NP_001104504.1; NM_001111034.2.
DR   RefSeq; NP_001104505.1; NM_001111035.2.
DR   RefSeq; NP_001104506.1; NM_001111036.2.
DR   RefSeq; NP_001308952.1; NM_001322023.1.
DR   RefSeq; NP_001602.1; NM_001611.4.
DR   RefSeq; XP_005259995.1; XM_005259938.1.
DR   RefSeq; XP_011526371.1; XM_011528069.2.
DR   PDB; 1WAR; X-ray; 2.22 A; A=22-325.
DR   PDB; 2BQ8; X-ray; 2.20 A; X=22-325.
DR   PDBsum; 1WAR; -.
DR   PDBsum; 2BQ8; -.
DR   SMR; P13686; -.
DR   BioGRID; 106570; 25.
DR   IntAct; P13686; 12.
DR   MINT; P13686; -.
DR   STRING; 9606.ENSP00000468767; -.
DR   DEPOD; ACP5; -.
DR   GlyGen; P13686; 3 sites.
DR   iPTMnet; P13686; -.
DR   PhosphoSitePlus; P13686; -.
DR   BioMuta; ACP5; -.
DR   DMDM; 56757583; -.
DR   jPOST; P13686; -.
DR   MassIVE; P13686; -.
DR   PaxDb; P13686; -.
DR   PeptideAtlas; P13686; -.
DR   PRIDE; P13686; -.
DR   ProteomicsDB; 52960; -.
DR   Antibodypedia; 25921; 559 antibodies.
DR   DNASU; 54; -.
DR   Ensembl; ENST00000218758; ENSP00000218758; ENSG00000102575.
DR   Ensembl; ENST00000412435; ENSP00000392374; ENSG00000102575.
DR   Ensembl; ENST00000648477; ENSP00000496973; ENSG00000102575.
DR   GeneID; 54; -.
DR   KEGG; hsa:54; -.
DR   UCSC; uc002msg.5; human.
DR   CTD; 54; -.
DR   DisGeNET; 54; -.
DR   GeneCards; ACP5; -.
DR   HGNC; HGNC:124; ACP5.
DR   HPA; ENSG00000102575; Tissue enhanced (adipose tissue, lung).
DR   MalaCards; ACP5; -.
DR   MIM; 171640; gene.
DR   MIM; 607944; phenotype.
DR   neXtProt; NX_P13686; -.
DR   OpenTargets; ENSG00000102575; -.
DR   Orphanet; 1855; Spondyloenchondrodysplasia.
DR   PharmGKB; PA24448; -.
DR   VEuPathDB; HostDB:ENSG00000102575.10; -.
DR   eggNOG; KOG2679; Eukaryota.
DR   GeneTree; ENSGT00390000016735; -.
DR   HOGENOM; CLU_043332_1_0_1; -.
DR   InParanoid; P13686; -.
DR   OMA; RFHYGSE; -.
DR   OrthoDB; 711825at2759; -.
DR   PhylomeDB; P13686; -.
DR   TreeFam; TF313175; -.
DR   BRENDA; 3.1.3.2; 2681.
DR   PathwayCommons; P13686; -.
DR   Reactome; R-HSA-196843; Vitamin B2 (riboflavin) metabolism.
DR   SABIO-RK; P13686; -.
DR   SIGNOR; P13686; -.
DR   BioGRID-ORCS; 54; 7 hits in 870 CRISPR screens.
DR   ChiTaRS; ACP5; human.
DR   EvolutionaryTrace; P13686; -.
DR   GeneWiki; Tartrate-resistant_acid_phosphatase; -.
DR   GenomeRNAi; 54; -.
DR   Pharos; P13686; Tbio.
DR   PRO; PR:P13686; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P13686; protein.
DR   Bgee; ENSG00000102575; Expressed in periodontal ligament and 177 other tissues.
DR   ExpressionAtlas; P13686; baseline and differential.
DR   Genevisible; P13686; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0003993; F:acid phosphatase activity; IBA:GO_Central.
DR   GO; GO:0008199; F:ferric iron binding; IDA:UniProtKB.
DR   GO; GO:0008198; F:ferrous iron binding; IDA:UniProtKB.
DR   GO; GO:0060349; P:bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0045453; P:bone resorption; IBA:GO_Central.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; IEA:Ensembl.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; IEA:Ensembl.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0032929; P:negative regulation of superoxide anion generation; IEA:Ensembl.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IBA:GO_Central.
DR   GO; GO:0034097; P:response to cytokine; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0006771; P:riboflavin metabolic process; TAS:Reactome.
DR   CDD; cd07378; MPP_ACP5; 1.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR024927; Acid_PPase.
DR   InterPro; IPR004843; Calcineurin-like_PHP_ApaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   Pfam; PF00149; Metallophos; 1.
DR   PIRSF; PIRSF000898; Acid_Ptase_5; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disease variant; Disulfide bond;
KW   Glycoprotein; Hydrolase; Iron; Lysosome; Metal-binding; Reference proteome;
KW   Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000269|PubMed:1477968,
FT                   ECO:0000269|PubMed:2334436, ECO:0000269|PubMed:2610679,
FT                   ECO:0000269|PubMed:2775236"
FT   CHAIN           22..325
FT                   /note="Tartrate-resistant acid phosphatase type 5"
FT                   /id="PRO_0000023981"
FT   METAL           33
FT                   /note="Iron 1"
FT   METAL           71
FT                   /note="Iron 1"
FT   METAL           71
FT                   /note="Iron 2"
FT   METAL           74
FT                   /note="Iron 1"
FT   METAL           110
FT                   /note="Iron 2"
FT   METAL           205
FT                   /note="Iron 2"
FT   METAL           240
FT                   /note="Iron 2"
FT   METAL           242
FT                   /note="Iron 1"
FT   CARBOHYD        116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15993892"
FT   CARBOHYD        147
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        161..219
FT                   /evidence="ECO:0000250"
FT   VARIANT         52
FT                   /note="K -> M (in SPENCDI)"
FT                   /evidence="ECO:0000269|PubMed:21217752"
FT                   /id="VAR_065920"
FT   VARIANT         89
FT                   /note="T -> I (in SPENCDI; dbSNP:rs387906668)"
FT                   /evidence="ECO:0000269|PubMed:21217755"
FT                   /id="VAR_065921"
FT   VARIANT         109
FT                   /note="G -> R (in SPENCDI; dbSNP:rs781050795)"
FT                   /evidence="ECO:0000269|PubMed:21217752"
FT                   /id="VAR_065922"
FT   VARIANT         148
FT                   /note="V -> M (in dbSNP:rs2305799)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_020602"
FT   VARIANT         200
FT                   /note="V -> M (in dbSNP:rs2229531)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_020603"
FT   VARIANT         201
FT                   /note="L -> P (in SPENCDI; dbSNP:rs387906672)"
FT                   /evidence="ECO:0000269|PubMed:21217752"
FT                   /id="VAR_065923"
FT   VARIANT         215
FT                   /note="G -> R (in SPENCDI; dbSNP:rs781199182)"
FT                   /evidence="ECO:0000269|PubMed:21217752,
FT                   ECO:0000269|PubMed:21217755"
FT                   /id="VAR_065924"
FT   VARIANT         221
FT                   /note="V -> I (in dbSNP:rs2229532)"
FT                   /id="VAR_029288"
FT   VARIANT         241
FT                   /note="D -> N (in SPENCDI)"
FT                   /evidence="ECO:0000269|PubMed:21217755"
FT                   /id="VAR_065925"
FT   VARIANT         262
FT                   /note="N -> H (in SPENCDI; dbSNP:rs1449857485)"
FT                   /evidence="ECO:0000269|PubMed:21217752"
FT                   /id="VAR_065926"
FT   VARIANT         264
FT                   /note="M -> K (in SPENCDI; dbSNP:rs387906670)"
FT                   /evidence="ECO:0000269|PubMed:21217752,
FT                   ECO:0000269|PubMed:21217755"
FT                   /id="VAR_065927"
FT   VARIANT         278
FT                   /note="Missing (in SPENCDI)"
FT                   /evidence="ECO:0000269|PubMed:21217752"
FT                   /id="VAR_065928"
FT   CONFLICT        45..46
FT                   /note="AR -> GP (in Ref. 1; AAA76849)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="E -> G (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="E -> Q (in Ref. 7; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        50
FT                   /note="N -> W (in Ref. 7; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        177..180
FT                   /note="DVKL -> LT (in Ref. 1; AAA76849)"
FT                   /evidence="ECO:0000305"
FT   STRAND          26..31
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           45..61
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          64..68
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   TURN            74..76
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           85..89
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   TURN            90..93
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           97..100
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          104..106
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           110..113
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           117..122
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           123..125
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          128..131
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          134..142
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          149..154
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           157..161
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           164..166
FT                   /evidence="ECO:0000244|PDB:1WAR"
FT   HELIX           178..194
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          198..203
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          211..214
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           218..223
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           225..230
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          235..238
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          240..248
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          254..258
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   HELIX           271..273
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          279..283
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          291..297
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          299..308
FT                   /evidence="ECO:0000244|PDB:2BQ8"
FT   STRAND          313..320
FT                   /evidence="ECO:0000244|PDB:2BQ8"
SQ   SEQUENCE   325 AA;  36599 MW;  079174A71A5BA264 CRC64;
     MDMWTALLIL QALLLPSLAD GATPALRFVA VGDWGGVPNA PFHTAREMAN AKEIARTVQI
     LGADFILSLG DNFYFTGVQD INDKRFQETF EDVFSDRSLR KVPWYVLAGN HDHLGNVSAQ
     IAYSKISKRW NFPSPFYRLH FKIPQTNVSV AIFMLDTVTL CGNSDDFLSQ QPERPRDVKL
     ARTQLSWLKK QLAAAREDYV LVAGHYPVWS IAEHGPTHCL VKQLRPLLAT YGVTAYLCGH
     DHNLQYLQDE NGVGYVLSGA GNFMDPSKRH QRKVPNGYLR FHYGTEDSLG GFAYVEISSK
     EMTVTYIEAS GKSLFKTRLP RRARP
//
ID   PRS6A_HUMAN             Reviewed;         439 AA.
AC   P17980; B2R8V1; Q3B757; Q3B865; Q53HU5; Q6GPG8; Q6IBS1; Q96HD3;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2002, sequence version 3.
DT   10-FEB-2021, entry version 225.
DE   RecName: Full=26S proteasome regulatory subunit 6A;
DE   AltName: Full=26S proteasome AAA-ATPase subunit RPT5;
DE   AltName: Full=Proteasome 26S subunit ATPase 3;
DE   AltName: Full=Proteasome subunit P50;
DE   AltName: Full=Tat-binding protein 1;
DE            Short=TBP-1;
GN   Name=PSMC3; Synonyms=TBP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8419915; DOI=10.1073/pnas.90.1.138;
RA   Ohana B., Moore P.A., Ruben S.M., Southgate C.D., Green M.R., Rosen C.A.;
RT   "The type 1 human immunodeficiency virus Tat binding protein is a
RT   transcriptional activator belonging to an additional family of
RT   evolutionarily conserved genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:138-142(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, Lung, and Peripheral nerve;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-439.
RC   TISSUE=Adipose tissue;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-439, AND INTERACTION WITH HIV-1 TAT.
RX   PubMed=2194290; DOI=10.1126/science.2194290;
RA   Nelbock P., Dillion P.J., Perkins A., Rosen C.A.;
RT   "A cDNA for a protein that interacts with the human immunodeficiency virus
RT   Tat transactivator.";
RL   Science 248:1650-1653(1990).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 36-439.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PROTEIN SEQUENCE OF 130-144; 156-171; 174-233; 251-266; 277-294; 309-327;
RP   335-344; 351-362; 372-386 AND 398-409, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8621709; DOI=10.1074/jbc.271.6.3112;
RA   Demartino G.N., Proske R.J., Moomaw C.R., Strong A.A., Song X.,
RA   Hisamatsu H., Tanaka K., Slaughter C.A.;
RT   "Identification, purification, and characterization of a PA700-dependent
RT   activator of the proteasome.";
RL   J. Biol. Chem. 271:3112-3118(1996).
RN   [10]
RP   FUNCTION.
RX   PubMed=1317798; DOI=10.1111/j.1432-1033.1992.tb16961.x;
RA   Kanayama H.O., Tamura T., Ugai S., Kagawa S., Tanahashi N., Yoshimura T.,
RA   Tanaka K., Ichihara A.;
RT   "Demonstration that a human 26S proteolytic complex consists of a
RT   proteasome and multiple associated protein components and hydrolyzes ATP
RT   and ubiquitin-ligated proteins by closely linked mechanisms.";
RL   Eur. J. Biochem. 206:567-578(1992).
RN   [11]
RP   INTERACTION WITH PAAF1.
RX   PubMed=15831487; DOI=10.1128/mcb.25.9.3842-3853.2005;
RA   Park Y., Hwang Y.-P., Lee J.-S., Seo S.-H., Yoon S.K., Yoon J.-B.;
RT   "Proteasomal ATPase-associated factor 1 negatively regulates proteasome
RT   activity by interacting with proteasomal ATPases.";
RL   Mol. Cell. Biol. 25:3842-3853(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human 26S
RT   proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [13]
RP   SUMOYLATION.
RX   PubMed=17709345; DOI=10.1093/nar/gkm617;
RA   Jakobs A., Himstedt F., Funk M., Korn B., Gaestel M., Niedenthal R.;
RT   "Ubc9 fusion-directed SUMOylation identifies constitutive and inducible
RT   SUMOylation.";
RL   Nucleic Acids Res. 35:E109-E109(2007).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-9, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-9, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9 AND SER-376, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF 1-440, AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [22]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS) OF 1-440, AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated proteins.
CC       This complex plays a key role in the maintenance of protein homeostasis
CC       by removing misfolded or damaged proteins, which could impair cellular
CC       functions, and by removing proteins whose functions are no longer
CC       required. Therefore, the proteasome participates in numerous cellular
CC       processes, including cell cycle progression, apoptosis, or DNA damage
CC       repair. PSMC3 belongs to the heterohexameric ring of AAA (ATPases
CC       associated with diverse cellular activities) proteins that unfolds
CC       ubiquitinated target proteins that are concurrently translocated into a
CC       proteolytic chamber and degraded into peptides.
CC       {ECO:0000269|PubMed:1317798}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle complex.
CC       The 26S proteasome consists of a 20S core particle (CP) and two 19S
CC       regulatory subunits (RP). The regulatory particle is made of a lid
CC       composed of 9 subunits, a base containing 6 ATPases including PSMC3 and
CC       few additional components (PubMed:27428775, PubMed:27342858). Interacts
CC       with PAAF1 (PubMed:15831487). {ECO:0000269|PubMed:15831487,
CC       ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat.
CC       {ECO:0000269|PubMed:2194290}.
CC   -!- INTERACTION:
CC       P17980; Q9Y2J4: AMOTL2; NbExp=5; IntAct=EBI-359720, EBI-746752;
CC       P17980; Q9Y2J4-4: AMOTL2; NbExp=5; IntAct=EBI-359720, EBI-10187270;
CC       P17980; P05067: APP; NbExp=6; IntAct=EBI-359720, EBI-77613;
CC       P17980; P54253: ATXN1; NbExp=7; IntAct=EBI-359720, EBI-930964;
CC       P17980; P12532: CKMT1B; NbExp=3; IntAct=EBI-359720, EBI-1050662;
CC       P17980; Q14203-5: DCTN1; NbExp=3; IntAct=EBI-359720, EBI-25840379;
CC       P17980; Q9C005: DPY30; NbExp=3; IntAct=EBI-359720, EBI-744973;
CC       P17980; Q9NVF7: FBXO28; NbExp=4; IntAct=EBI-359720, EBI-740282;
CC       P17980; O43464: HTRA2; NbExp=3; IntAct=EBI-359720, EBI-517086;
CC       P17980; P42858: HTT; NbExp=6; IntAct=EBI-359720, EBI-466029;
CC       P17980; O14561: NDUFAB1; NbExp=6; IntAct=EBI-359720, EBI-1246261;
CC       P17980; P17980: PSMC3; NbExp=4; IntAct=EBI-359720, EBI-359720;
CC       P17980; P62333: PSMC6; NbExp=15; IntAct=EBI-359720, EBI-357669;
CC       P17980; O00233: PSMD9; NbExp=16; IntAct=EBI-359720, EBI-750973;
CC       P17980; P37840: SNCA; NbExp=6; IntAct=EBI-359720, EBI-985879;
CC       P17980; P00441: SOD1; NbExp=3; IntAct=EBI-359720, EBI-990792;
CC       P17980; Q9BUZ4: TRAF4; NbExp=4; IntAct=EBI-359720, EBI-3650647;
CC       P17980; A8K2R3; NbExp=3; IntAct=EBI-359720, EBI-9977437;
CC       P17980; P03255-1; Xeno; NbExp=2; IntAct=EBI-359720, EBI-6692439;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus {ECO:0000305}.
CC       Note=Colocalizes with TRIM5 in the cytoplasmic bodies.
CC       {ECO:0000250|UniProtKB:O88685}.
CC   -!- PTM: Sumoylated by UBE2I in response to MEKK1-mediated stimuli.
CC       {ECO:0000269|PubMed:17709345}.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI07805.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK313518; BAG36298.1; -; mRNA.
DR   EMBL; CH471064; EAW67916.1; -; Genomic_DNA.
DR   EMBL; BC008713; AAH08713.4; -; mRNA.
DR   EMBL; BC073165; AAH73165.3; -; mRNA.
DR   EMBL; BC106920; AAI06921.1; -; mRNA.
DR   EMBL; BC107804; AAI07805.1; ALT_INIT; mRNA.
DR   EMBL; AK222485; BAD96205.1; -; mRNA.
DR   EMBL; M34079; AAA36666.1; -; mRNA.
DR   EMBL; CR456731; CAG33012.1; -; mRNA.
DR   CCDS; CCDS7935.1; -.
DR   PIR; A34832; A34832.
DR   RefSeq; NP_002795.2; NM_002804.4.
DR   PDB; 5GJQ; EM; 4.50 A; M=1-439.
DR   PDB; 5GJR; EM; 3.50 A; 0/M=1-439.
DR   PDB; 5L4G; EM; 4.02 A; M=1-439.
DR   PDB; 5LN3; EM; 6.80 A; M=1-439.
DR   PDB; 5M32; EM; 3.80 A; g=1-439.
DR   PDB; 5T0C; EM; 3.80 A; AF/BF=1-439.
DR   PDB; 5T0G; EM; 4.40 A; F=1-439.
DR   PDB; 5T0H; EM; 6.80 A; F=1-439.
DR   PDB; 5T0I; EM; 8.00 A; F=1-439.
DR   PDB; 5T0J; EM; 8.00 A; F=1-439.
DR   PDB; 5VFP; EM; 4.20 A; F=44-439.
DR   PDB; 5VFQ; EM; 4.20 A; F=44-439.
DR   PDB; 5VFR; EM; 4.90 A; F=44-439.
DR   PDB; 5VFS; EM; 3.60 A; F=1-439.
DR   PDB; 5VFT; EM; 7.00 A; F=63-439.
DR   PDB; 5VFU; EM; 5.80 A; F=63-439.
DR   PDB; 5VGZ; EM; 3.70 A; F=53-167.
DR   PDB; 5VHF; EM; 5.70 A; F=53-432.
DR   PDB; 5VHH; EM; 6.10 A; F=53-432.
DR   PDB; 5VHI; EM; 6.80 A; F=53-432.
DR   PDB; 5VHJ; EM; 8.50 A; F=166-432.
DR   PDB; 5VHM; EM; 8.30 A; F=166-432.
DR   PDB; 5VHN; EM; 7.30 A; F=166-432.
DR   PDB; 5VHO; EM; 8.30 A; F=166-432.
DR   PDB; 5VHP; EM; 7.90 A; F=166-432.
DR   PDB; 5VHQ; EM; 8.90 A; F=166-432.
DR   PDB; 5VHR; EM; 7.70 A; F=166-432.
DR   PDB; 5VHS; EM; 8.80 A; F=53-432.
DR   PDB; 6MSB; EM; 3.00 A; F=1-439.
DR   PDB; 6MSD; EM; 3.20 A; F=1-439.
DR   PDB; 6MSE; EM; 3.30 A; F=1-439.
DR   PDB; 6MSG; EM; 3.50 A; F=1-439.
DR   PDB; 6MSH; EM; 3.60 A; F=1-439.
DR   PDB; 6MSJ; EM; 3.30 A; F=1-439.
DR   PDB; 6MSK; EM; 3.20 A; F=1-439.
DR   PDB; 6WJD; EM; 4.80 A; F=1-439.
DR   PDB; 6WJN; EM; 5.70 A; F=44-439.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4G; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 5VFP; -.
DR   PDBsum; 5VFQ; -.
DR   PDBsum; 5VFR; -.
DR   PDBsum; 5VFS; -.
DR   PDBsum; 5VFT; -.
DR   PDBsum; 5VFU; -.
DR   PDBsum; 5VGZ; -.
DR   PDBsum; 5VHF; -.
DR   PDBsum; 5VHH; -.
DR   PDBsum; 5VHI; -.
DR   PDBsum; 5VHJ; -.
DR   PDBsum; 5VHM; -.
DR   PDBsum; 5VHN; -.
DR   PDBsum; 5VHO; -.
DR   PDBsum; 5VHP; -.
DR   PDBsum; 5VHQ; -.
DR   PDBsum; 5VHR; -.
DR   PDBsum; 5VHS; -.
DR   PDBsum; 6MSB; -.
DR   PDBsum; 6MSD; -.
DR   PDBsum; 6MSE; -.
DR   PDBsum; 6MSG; -.
DR   PDBsum; 6MSH; -.
DR   PDBsum; 6MSJ; -.
DR   PDBsum; 6MSK; -.
DR   PDBsum; 6WJD; -.
DR   PDBsum; 6WJN; -.
DR   SMR; P17980; -.
DR   BioGRID; 111675; 268.
DR   ComplexPortal; CPX-5993; 26S Proteasome complex.
DR   CORUM; P17980; -.
DR   DIP; DIP-27555N; -.
DR   IntAct; P17980; 140.
DR   MINT; P17980; -.
DR   STRING; 9606.ENSP00000481029; -.
DR   ChEMBL; CHEMBL2364701; -.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   iPTMnet; P17980; -.
DR   MetOSite; P17980; -.
DR   PhosphoSitePlus; P17980; -.
DR   SwissPalm; P17980; -.
DR   BioMuta; PSMC3; -.
DR   DMDM; 20532406; -.
DR   REPRODUCTION-2DPAGE; IPI00018398; -.
DR   EPD; P17980; -.
DR   jPOST; P17980; -.
DR   MassIVE; P17980; -.
DR   MaxQB; P17980; -.
DR   PaxDb; P17980; -.
DR   PeptideAtlas; P17980; -.
DR   PRIDE; P17980; -.
DR   ProteomicsDB; 53537; -.
DR   Antibodypedia; 1816; 501 antibodies.
DR   DNASU; 5702; -.
DR   Ensembl; ENST00000298852; ENSP00000298852; ENSG00000165916.
DR   Ensembl; ENST00000619920; ENSP00000481029; ENSG00000165916.
DR   GeneID; 5702; -.
DR   KEGG; hsa:5702; -.
DR   UCSC; uc001nfh.2; human.
DR   CTD; 5702; -.
DR   DisGeNET; 5702; -.
DR   GeneCards; PSMC3; -.
DR   HGNC; HGNC:9549; PSMC3.
DR   HPA; ENSG00000165916; Tissue enhanced (skeletal).
DR   MIM; 186852; gene.
DR   neXtProt; NX_P17980; -.
DR   NIAGADS; ENSG00000165916; -.
DR   OpenTargets; ENSG00000165916; -.
DR   PharmGKB; PA33894; -.
DR   VEuPathDB; HostDB:ENSG00000165916.8; -.
DR   eggNOG; KOG0652; Eukaryota.
DR   GeneTree; ENSGT01000000214468; -.
DR   InParanoid; P17980; -.
DR   OMA; KPTEQYT; -.
DR   OrthoDB; 571919at2759; -.
DR   PhylomeDB; P17980; -.
DR   TreeFam; TF105648; -.
DR   PathwayCommons; P17980; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-75815; Ubiquitin-dependent degradation of Cyclin D.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-9604323; Negative regulation of NOTCH4 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   BioGRID-ORCS; 5702; 768 hits in 877 CRISPR screens.
DR   ChiTaRS; PSMC3; human.
DR   GeneWiki; PSMC3; -.
DR   GenomeRNAi; 5702; -.
DR   Pharos; P17980; Tbio.
DR   PRO; PR:P17980; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P17980; protein.
DR   Bgee; ENSG00000165916; Expressed in heart left ventricle and 237 other tissues.
DR   ExpressionAtlas; P17980; baseline and differential.
DR   Genevisible; P17980; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:GO_Central.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0022624; C:proteasome accessory complex; ISS:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0008540; C:proteasome regulatory particle, base subcomplex; IBA:GO_Central.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0036402; F:proteasome-activating ATPase activity; IEA:InterPro.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; TAS:Reactome.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0001824; P:blastocyst development; IEA:Ensembl.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0043921; P:modulation by host of viral transcription; IDA:GO_Central.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0038061; P:NIK/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0045899; P:positive regulation of RNA polymerase II transcription preinitiation complex assembly; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:GO_Central.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; TAS:Reactome.
DR   GO; GO:1901990; P:regulation of mitotic cell cycle phase transition; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; TAS:Reactome.
DR   InterPro; IPR005937; 26S_Psome_P45-like.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR041569; AAA_lid_3.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR032501; Prot_ATP_ID_OB.
DR   InterPro; IPR035254; PSMC3.
DR   PANTHER; PTHR23073:SF90; PTHR23073:SF90; 1.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF17862; AAA_lid_3; 1.
DR   Pfam; PF16450; Prot_ATP_ID_OB; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR01242; 26Sp45; 1.
DR   PROSITE; PS00674; AAA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Proteasome; Reference proteome; Ubl conjugation.
FT   CHAIN           1..439
FT                   /note="26S proteasome regulatory subunit 6A"
FT                   /id="PRO_0000084698"
FT   NP_BIND         227..234
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17323924,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CONFLICT        356
FT                   /note="M -> T (in Ref. 5; BAD96205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        409
FT                   /note="R -> A (in Ref. 6; AAA36666)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   439 AA;  49204 MW;  0E443465DDDEBB0B CRC64;
     MNLLPNIESP VTRQEKMATV WDEAEQDGIG EEVLKMSTEE IIQRTRLLDS EIKIMKSEVL
     RVTHELQAMK DKIKENSEKI KVNKTLPYLV SNVIELLDVD PNDQEEDGAN IDLDSQRKGK
     CAVIKTSTRQ TYFLPVIGLV DAEKLKPGDL VGVNKDSYLI LETLPTEYDS RVKAMEVDER
     PTEQYSDIGG LDKQIQELVE AIVLPMNHKE KFENLGIQPP KGVLMYGPPG TGKTLLARAC
     AAQTKATFLK LAGPQLVQMF IGDGAKLVRD AFALAKEKAP SIIFIDELDA IGTKRFDSEK
     AGDREVQRTM LELLNQLDGF QPNTQVKVIA ATNRVDILDP ALLRSGRLDR KIEFPMPNEE
     ARARIMQIHS RKMNVSPDVN YEELARCTDD FNGAQCKAVC VEAGMIALRR GATELTHEDY
     MEGILEVQAK KKANLQYYA
//
ID   PRR35_HUMAN             Reviewed;         571 AA.
AC   P0CG20; B8ZZ27; Q8N233; Q96AX3; Q96S23;
DT   15-JUN-2010, integrated into UniProtKB/Swiss-Prot.
DT   15-JUN-2010, sequence version 1.
DT   10-FEB-2021, entry version 65.
DE   RecName: Full=Proline-rich protein 35;
DE   AltName: Full=Uncharacterized protein RJD1;
GN   Name=PRR35; Synonyms=C16orf11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K., Tufarelli C.,
RA   Kearney L., Buckle V.J., Doggett N.A., Flint J., Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2 Mb of
RT   the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       P0CG20; Q8NFV4-4: ABHD11; NbExp=3; IntAct=EBI-11986293, EBI-12318443;
CC       P0CG20; Q03154: ACY1; NbExp=3; IntAct=EBI-11986293, EBI-742064;
CC       P0CG20; Q8NEU8: APPL2; NbExp=3; IntAct=EBI-11986293, EBI-741261;
CC       P0CG20; Q96C12: ARMC5; NbExp=3; IntAct=EBI-11986293, EBI-6425121;
CC       P0CG20; Q8WXK1: ASB15; NbExp=3; IntAct=EBI-11986293, EBI-12809012;
CC       P0CG20; Q9BUH8: BEGAIN; NbExp=3; IntAct=EBI-11986293, EBI-742722;
CC       P0CG20; Q96CA5: BIRC7; NbExp=3; IntAct=EBI-11986293, EBI-517623;
CC       P0CG20; Q9NP55: BPIFA1; NbExp=3; IntAct=EBI-11986293, EBI-953896;
CC       P0CG20; Q9H5F2: C11orf1; NbExp=3; IntAct=EBI-11986293, EBI-718615;
CC       P0CG20; Q5BKX5-3: C19orf54; NbExp=3; IntAct=EBI-11986293, EBI-11976299;
CC       P0CG20; Q9BWT7: CARD10; NbExp=3; IntAct=EBI-11986293, EBI-3866279;
CC       P0CG20; Q9NZN8: CNOT2; NbExp=3; IntAct=EBI-11986293, EBI-743033;
CC       P0CG20; O43186: CRX; NbExp=3; IntAct=EBI-11986293, EBI-748171;
CC       P0CG20; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-11986293, EBI-3867333;
CC       P0CG20; Q8IYI6: EXOC8; NbExp=3; IntAct=EBI-11986293, EBI-742102;
CC       P0CG20; A1KXE4-2: FAM168B; NbExp=3; IntAct=EBI-11986293, EBI-12193763;
CC       P0CG20; Q13643: FHL3; NbExp=3; IntAct=EBI-11986293, EBI-741101;
CC       P0CG20; O94915-2: FRYL; NbExp=3; IntAct=EBI-11986293, EBI-12023420;
CC       P0CG20; O75420: GIGYF1; NbExp=3; IntAct=EBI-11986293, EBI-947774;
CC       P0CG20; O75791: GRAP2; NbExp=3; IntAct=EBI-11986293, EBI-740418;
CC       P0CG20; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-11986293, EBI-748420;
CC       P0CG20; Q96ED9-2: HOOK2; NbExp=3; IntAct=EBI-11986293, EBI-10961706;
CC       P0CG20; P84074: HPCA; NbExp=3; IntAct=EBI-11986293, EBI-12197079;
CC       P0CG20; Q16082: HSPB2; NbExp=3; IntAct=EBI-11986293, EBI-739395;
CC       P0CG20; Q1MX18: INSC; NbExp=3; IntAct=EBI-11986293, EBI-12081118;
CC       P0CG20; Q5TA45: INTS11; NbExp=3; IntAct=EBI-11986293, EBI-748258;
CC       P0CG20; P14923: JUP; NbExp=3; IntAct=EBI-11986293, EBI-702484;
CC       P0CG20; Q53HC5: KLHL26; NbExp=3; IntAct=EBI-11986293, EBI-724915;
CC       P0CG20; Q15323: KRT31; NbExp=3; IntAct=EBI-11986293, EBI-948001;
CC       P0CG20; O76011: KRT34; NbExp=5; IntAct=EBI-11986293, EBI-1047093;
CC       P0CG20; Q92764: KRT35; NbExp=3; IntAct=EBI-11986293, EBI-1058674;
CC       P0CG20; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-11986293, EBI-10172290;
CC       P0CG20; P59990: KRTAP12-1; NbExp=3; IntAct=EBI-11986293, EBI-10210845;
CC       P0CG20; Q6PEX3: KRTAP26-1; NbExp=3; IntAct=EBI-11986293, EBI-3957672;
CC       P0CG20; Q3LI64: KRTAP6-1; NbExp=3; IntAct=EBI-11986293, EBI-12111050;
CC       P0CG20; Q3LI66: KRTAP6-2; NbExp=5; IntAct=EBI-11986293, EBI-11962084;
CC       P0CG20; Q8IUC2: KRTAP8-1; NbExp=3; IntAct=EBI-11986293, EBI-10261141;
CC       P0CG20; Q14847-2: LASP1; NbExp=3; IntAct=EBI-11986293, EBI-9088686;
CC       P0CG20; Q17RB8: LONRF1; NbExp=3; IntAct=EBI-11986293, EBI-2341787;
CC       P0CG20; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-11986293, EBI-741037;
CC       P0CG20; Q9Y5V3: MAGED1; NbExp=3; IntAct=EBI-11986293, EBI-716006;
CC       P0CG20; P59942: MCCD1; NbExp=3; IntAct=EBI-11986293, EBI-11987923;
CC       P0CG20; Q13064: MKRN3; NbExp=3; IntAct=EBI-11986293, EBI-2340269;
CC       P0CG20; Q4VC12: MSS51; NbExp=3; IntAct=EBI-11986293, EBI-11599933;
CC       P0CG20; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-11986293, EBI-11522433;
CC       P0CG20; O15049: N4BP3; NbExp=3; IntAct=EBI-11986293, EBI-2512055;
CC       P0CG20; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-11986293, EBI-22310682;
CC       P0CG20; O43482: OIP5; NbExp=3; IntAct=EBI-11986293, EBI-536879;
CC       P0CG20; Q8TDS5: OXER1; NbExp=3; IntAct=EBI-11986293, EBI-12813389;
CC       P0CG20; Q99471: PFDN5; NbExp=3; IntAct=EBI-11986293, EBI-357275;
CC       P0CG20; Q9UPG8: PLAGL2; NbExp=3; IntAct=EBI-11986293, EBI-2876622;
CC       P0CG20; Q9Y3C6: PPIL1; NbExp=3; IntAct=EBI-11986293, EBI-2557649;
CC       P0CG20; Q96KQ4: PPP1R13B; NbExp=3; IntAct=EBI-11986293, EBI-1105153;
CC       P0CG20; P86480: PRR20D; NbExp=3; IntAct=EBI-11986293, EBI-12754095;
CC       P0CG20; O43586: PSTPIP1; NbExp=3; IntAct=EBI-11986293, EBI-1050964;
CC       P0CG20; Q93062-3: RBPMS; NbExp=3; IntAct=EBI-11986293, EBI-740343;
CC       P0CG20; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-11986293, EBI-6257312;
CC       P0CG20; Q53HV7-2: SMUG1; NbExp=3; IntAct=EBI-11986293, EBI-12275818;
CC       P0CG20; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-11986293, EBI-11959123;
CC       P0CG20; O60806: TBX19; NbExp=3; IntAct=EBI-11986293, EBI-12096770;
CC       P0CG20; Q08117-2: TLE5; NbExp=5; IntAct=EBI-11986293, EBI-11741437;
CC       P0CG20; P14373: TRIM27; NbExp=3; IntAct=EBI-11986293, EBI-719493;
CC       P0CG20; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-11986293, EBI-2130429;
CC       P0CG20; Q86UV6-2: TRIM74; NbExp=3; IntAct=EBI-11986293, EBI-10259086;
CC       P0CG20; Q6DKK2: TTC19; NbExp=3; IntAct=EBI-11986293, EBI-948354;
CC       P0CG20; Q14166: TTLL12; NbExp=3; IntAct=EBI-11986293, EBI-923010;
CC       P0CG20; Q8TF42: UBASH3B; NbExp=3; IntAct=EBI-11986293, EBI-1380492;
CC       P0CG20; Q5T124-6: UBXN11; NbExp=3; IntAct=EBI-11986293, EBI-11524408;
CC       P0CG20; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-11986293, EBI-11975223;
CC       P0CG20; Q9H0C1: ZMYND12; NbExp=3; IntAct=EBI-11986293, EBI-12030590;
CC       P0CG20; Q8N720: ZNF655; NbExp=3; IntAct=EBI-11986293, EBI-625509;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK61234.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE006464; AAK61234.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; Z97986; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85802.1; -; Genomic_DNA.
DR   EMBL; BC016613; AAH16613.1; -; mRNA.
DR   CCDS; CCDS45365.1; -.
DR   RefSeq; NP_660313.1; NM_145270.2.
DR   RefSeq; XP_016878448.1; XM_017022959.1.
DR   RefSeq; XP_016878449.1; XM_017022960.1.
DR   BioGRID; 126978; 82.
DR   IntAct; P0CG20; 71.
DR   STRING; 9606.ENSP00000386499; -.
DR   iPTMnet; P0CG20; -.
DR   PhosphoSitePlus; P0CG20; -.
DR   BioMuta; PRR35; -.
DR   DMDM; 298351619; -.
DR   jPOST; P0CG20; -.
DR   PaxDb; P0CG20; -.
DR   PeptideAtlas; P0CG20; -.
DR   PRIDE; P0CG20; -.
DR   ProteomicsDB; 52454; -.
DR   Antibodypedia; 68294; 5 antibodies.
DR   Ensembl; ENST00000409413; ENSP00000386499; ENSG00000161992.
DR   GeneID; 146325; -.
DR   KEGG; hsa:146325; -.
DR   UCSC; uc002chk.4; human.
DR   CTD; 146325; -.
DR   DisGeNET; 146325; -.
DR   GeneCards; PRR35; -.
DR   HGNC; HGNC:14139; PRR35.
DR   HPA; ENSG00000161992; Tissue enriched (brain).
DR   neXtProt; NX_P0CG20; -.
DR   OpenTargets; ENSG00000161992; -.
DR   PharmGKB; PA25524; -.
DR   VEuPathDB; HostDB:ENSG00000161992.5; -.
DR   eggNOG; ENOG502QRT7; Eukaryota.
DR   GeneTree; ENSGT00530000063870; -.
DR   HOGENOM; CLU_022992_0_0_1; -.
DR   InParanoid; P0CG20; -.
DR   OMA; SSHTTKC; -.
DR   OrthoDB; 485654at2759; -.
DR   PhylomeDB; P0CG20; -.
DR   TreeFam; TF331381; -.
DR   PathwayCommons; P0CG20; -.
DR   BioGRID-ORCS; 146325; 5 hits in 859 CRISPR screens.
DR   GenomeRNAi; 146325; -.
DR   Pharos; P0CG20; Tdark.
DR   PRO; PR:P0CG20; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P0CG20; protein.
DR   Bgee; ENSG00000161992; Expressed in right hemisphere of cerebellum and 36 other tissues.
DR   Genevisible; P0CG20; HS.
DR   InterPro; IPR039363; ZNF750.
DR   InterPro; IPR039064; ZNF750_Znf.
DR   PANTHER; PTHR14678; PTHR14678; 1.
DR   Pfam; PF15269; zf-C2H2_7; 1.
PE   1: Evidence at protein level;
KW   Reference proteome.
FT   CHAIN           1..571
FT                   /note="Proline-rich protein 35"
FT                   /id="PRO_0000326184"
FT   COMPBIAS        83..401
FT                   /note="Pro-rich"
SQ   SEQUENCE   571 AA;  59354 MW;  7F15F84F05FF460E CRC64;
     MSREAGSCRV GTGARARSRK PKKPHYIPRP WGKPYNYKCF QCPFTCLEKS HLYNHMKYSL
     CKDSLSLLLD SPDWACRRGS TTPRPHAPTP DRPGESDPGR QPQGARPTGA APAPDLVVAD
     IHSLHCGGGP KSRAKGSPGP PPPVARATRK GPGPSGLLPE SWKPGMGGDP RGVGAGDMAS
     AGPEGSVPCY PPPAPGEFPE AHSLHLSLLG VNYPLSPGLF SYLGPSLAAA AHVPFLASAS
     PLLPPATAFP AVQPPQRPTP APRLYYPLLL EHTLGLPAGK AALAKAPVSP RSPSGTPAPG
     LLKVPVPGLG PWPRVTPRDP GQEGELERAA QSDPRRRLSL GSRLELPKAS PSLTRFCSRS
     SLPTGSSVML WPEDGDPGGP ETPGPEGPLP LQPRGPVPGS PEHVGEDLTR ALGDYARVEQ
     RLGQLGPAGG LAPRPLREQL GKIRLELLTI HQALEQAVRP PDAPLDLSVK RAPAKGPQAL
     GEAWGRPELG PVLTGGTPEP PGMLGPAAPQ PFSGHTTKCE ADSSVPPPGL PLAAPDDPVI
     PGSGWGTCVA TRSSQTPEAV CGLQSPQGAE V
//
ID   PRCD_HUMAN              Reviewed;          54 AA.
AC   Q00LT1; B9EJD4;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 1.
DT   10-FEB-2021, entry version 100.
DE   RecName: Full=Photoreceptor disk component PRCD {ECO:0000312|HGNC:HGNC:32528};
DE   AltName: Full=Progressive rod-cone degeneration protein {ECO:0000303|PubMed:16938425, ECO:0000303|PubMed:24992209};
GN   Name=PRCD {ECO:0000312|HGNC:HGNC:32528};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, VARIANTS RP36
RP   TYR-2 AND MET-30, VARIANT CYS-17, AND INVOLVEMENT IN RP36.
RX   PubMed=16938425; DOI=10.1016/j.ygeno.2006.07.007;
RA   Zangerl B., Goldstein O., Philp A.R., Lindauer S.J.P., Pearce-Kelling S.E.,
RA   Mullins R.F., Graphodatsky A.S., Ripoll D., Felix J.S., Stone E.M.,
RA   Acland G.M., Aguirre G.D.;
RT   "Identical mutation in a novel retinal gene causes progressive rod-cone
RT   degeneration in dogs and retinitis pigmentosa in humans.";
RL   Genomics 88:551-563(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, PALMITOYLATION, VARIANTS RP36 TYR-2 AND
RP   THR-25, AND CHARACTERIZATION OF VARIANTS RP36 TYR-2 AND THR-25.
RX   PubMed=24992209; DOI=10.1016/j.exer.2014.06.017;
RA   Remez L., Zobor D., Kohl S., Ben-Yosef T.;
RT   "The progressive rod-cone degeneration (PRCD) protein is secreted through
RT   the conventional ER/Golgi-dependent pathway.";
RL   Exp. Eye Res. 125:217-225(2014).
RN   [4]
RP   SUBCELLULAR LOCATION, PALMITOYLATION AT CYS-2, AND CHARACTERIZATION OF
RP   VARIANTS RP36 TYR-2 AND MET-30.
RX   PubMed=27613864; DOI=10.1074/jbc.m116.742767;
RA   Murphy J., Kolandaivelu S.;
RT   "Palmitoylation of Progressive Rod-Cone Degeneration (PRCD) Regulates
RT   Protein Stability and Localization.";
RL   J. Biol. Chem. 291:23036-23046(2016).
CC   -!- FUNCTION: Involved in vision. {ECO:0000269|PubMed:16938425,
CC       ECO:0000269|PubMed:24992209}.
CC   -!- SUBUNIT: Interacts with RHO/rhodopsin; the interaction promotes PRCD
CC       stability. {ECO:0000250|UniProtKB:Q00LT2}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, photoreceptor outer
CC       segment {ECO:0000269|PubMed:27613864}. Membrane
CC       {ECO:0000269|PubMed:27613864}; Lipid-anchor
CC       {ECO:0000269|PubMed:27613864}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q00LT2}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:24992209}. Golgi apparatus
CC       {ECO:0000269|PubMed:24992209}. Note=Localizes to photoreceptor disk
CC       membranes in the photoreceptor outer segment (PubMed:27613864). The
CC       secretion in media described in PubMed:24992209 is probably an
CC       experimental artifact (PubMed:24992209). {ECO:0000269|PubMed:24992209,
CC       ECO:0000269|PubMed:27613864}.
CC   -!- PTM: Palmitoylated at Cys-2 (PubMed:27613864). Palmitoylation is
CC       essential for protein stability and trafficking to the photoreceptor
CC       outer segment, but does not appear to be essential for membrane
CC       localization (PubMed:27613864). Probably palmitoylated by ZDHHC3
CC       (PubMed:27613864). {ECO:0000269|PubMed:27613864}.
CC   -!- PTM: Phosphorylated. {ECO:0000250|UniProtKB:E1B7R9}.
CC   -!- DISEASE: Retinitis pigmentosa 36 (RP36) [MIM:610599]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies. Retinitis
CC       pigmentosa is characterized by retinal pigment deposits visible on
CC       fundus examination and primary loss of rod photoreceptor cells followed
CC       by secondary loss of cone photoreceptors. Patients typically have night
CC       vision blindness and loss of midperipheral visual field. As their
CC       condition progresses, they lose their far peripheral visual field and
CC       eventually central vision as well. {ECO:0000269|PubMed:16938425,
CC       ECO:0000269|PubMed:24992209, ECO:0000269|PubMed:27613864}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the PRCD family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ390338; ABD17429.1; -; mRNA.
DR   EMBL; BC146898; AAI46899.1; -; mRNA.
DR   EMBL; BC146904; AAI46905.1; -; mRNA.
DR   CCDS; CCDS42382.1; -.
DR   RefSeq; NP_001071088.1; NM_001077620.2.
DR   RefSeq; XP_016880502.1; XM_017025013.1.
DR   RefSeq; XP_016880503.1; XM_017025014.1.
DR   RefSeq; XP_016880504.1; XM_017025015.1.
DR   BioGRID; 612840; 1.
DR   STRING; 9606.ENSP00000465932; -.
DR   iPTMnet; Q00LT1; -.
DR   PhosphoSitePlus; Q00LT1; -.
DR   SwissPalm; Q00LT1; -.
DR   BioMuta; PRCD; -.
DR   DMDM; 121939885; -.
DR   PaxDb; Q00LT1; -.
DR   PeptideAtlas; Q00LT1; -.
DR   PRIDE; Q00LT1; -.
DR   ProteomicsDB; 57903; -.
DR   Antibodypedia; 64642; 2 antibodies.
DR   Ensembl; ENST00000586148; ENSP00000465932; ENSG00000214140.
DR   Ensembl; ENST00000592014; ENSP00000467661; ENSG00000214140.
DR   GeneID; 768206; -.
DR   KEGG; hsa:768206; -.
DR   UCSC; uc002jrx.3; human.
DR   CTD; 768206; -.
DR   DisGeNET; 768206; -.
DR   GeneCards; PRCD; -.
DR   GeneReviews; PRCD; -.
DR   HGNC; HGNC:32528; PRCD.
DR   HPA; ENSG00000214140; Tissue enriched (retina).
DR   MalaCards; PRCD; -.
DR   MIM; 610598; gene.
DR   MIM; 610599; phenotype.
DR   neXtProt; NX_Q00LT1; -.
DR   OpenTargets; ENSG00000214140; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA162400025; -.
DR   VEuPathDB; HostDB:ENSG00000214140.10; -.
DR   eggNOG; ENOG502TE0N; Eukaryota.
DR   GeneTree; ENSGT00520000058096; -.
DR   HOGENOM; CLU_3175255_0_0_1; -.
DR   InParanoid; Q00LT1; -.
DR   OMA; RRCANRV; -.
DR   OrthoDB; 1379813at2759; -.
DR   PhylomeDB; Q00LT1; -.
DR   PathwayCommons; Q00LT1; -.
DR   BioGRID-ORCS; 768206; 4 hits in 866 CRISPR screens.
DR   GenomeRNAi; 768206; -.
DR   Pharos; Q00LT1; Tdark.
DR   PRO; PR:Q00LT1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q00LT1; protein.
DR   Bgee; ENSG00000214140; Expressed in right hemisphere of cerebellum and 168 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0042622; C:photoreceptor outer segment membrane; IDA:UniProtKB.
DR   GO; GO:0002046; F:opsin binding; IEA:Ensembl.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR027937; PRCD.
DR   PANTHER; PTHR38501; PTHR38501; 1.
DR   Pfam; PF15201; Rod_cone_degen; 1.
PE   1: Evidence at protein level;
KW   Cell projection; Disease variant; Endoplasmic reticulum; Golgi apparatus;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Reference proteome;
KW   Retinitis pigmentosa; Sensory transduction; Vision.
FT   CHAIN           1..54
FT                   /note="Photoreceptor disk component PRCD"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000280353"
FT   LIPID           2
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:27613864"
FT   VARIANT         2
FT                   /note="C -> Y (in RP36; loss of palmitoylation; reduced
FT                   protein stability; fails to localize to the photoreceptor
FT                   outer segment; dbSNP:rs121918369)"
FT                   /evidence="ECO:0000269|PubMed:16938425,
FT                   ECO:0000269|PubMed:24992209"
FT                   /id="VAR_031122"
FT   VARIANT         17
FT                   /note="R -> C (in dbSNP:rs375181336)"
FT                   /evidence="ECO:0000269|PubMed:16938425"
FT                   /id="VAR_031123"
FT   VARIANT         25
FT                   /note="P -> T (in RP36; no effect on protein level)"
FT                   /evidence="ECO:0000269|PubMed:24992209"
FT                   /id="VAR_078540"
FT   VARIANT         30
FT                   /note="V -> M (in RP36; unknown pathological significance;
FT                   no effect on protein stability; dbSNP:rs767439982)"
FT                   /evidence="ECO:0000269|PubMed:16938425,
FT                   ECO:0000269|PubMed:27613864"
FT                   /id="VAR_031124"
SQ   SEQUENCE   54 AA;  6007 MW;  701C17567D2FC54A CRC64;
     MCTTLFLLST LAMLWRRRFA NRVQPEPSDV DGAARGSSLD ADPQSSGREK EPLK
//
ID   PPT2_HUMAN              Reviewed;         302 AA.
AC   Q9UMR5; A2ABC9; A2ABD1; A2ARM7; A2BFH7; A2BFH9; A2BFI2; A8K9L4; B0S868;
AC   G8JLE1; O14799; Q0P6K0; Q5JP13; Q5JP14; Q5JQF0; Q5SSX4; Q5SSX5; Q5SSX6;
AC   Q5STJ4; Q5STJ5; Q5STJ6; Q6FI80; Q99945;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   10-FEB-2021, entry version 171.
DE   RecName: Full=Lysosomal thioesterase PPT2;
DE            Short=PPT-2;
DE            EC=3.1.2.-;
DE   AltName: Full=S-thioesterase G14;
DE   Flags: Precursor;
GN   Name=PPT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, GLYCOSYLATION, PH DEPENDENCE, AND
RP   VARIANT TRP-5.
RX   PubMed=9341199; DOI=10.1074/jbc.272.43.27456;
RA   Soyombo A.A., Hofmann S.L.;
RT   "Molecular cloning and expression of palmitoyl-protein thioesterase 2
RT   (PPT2), a homolog of lysosomal palmitoyl-protein thioesterase with a
RT   distinct substrate specificity.";
RL   J. Biol. Chem. 272:27456-27463(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), GLYCOSYLATION, FUNCTION, AND
RP   VARIANT TRP-5.
RX   PubMed=10417332; DOI=10.1042/bj3410679;
RA   Aguado B., Campbell R.D.;
RT   "Characterization of a human MHC class III region gene product with S-
RT   thioesterase activity.";
RL   Biochem. J. 341:679-689(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT TRP-5.
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-5.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT TRP-5.
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS TRP-5 AND
RP   GLU-34.
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D.,
RA   Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS TRP-5 AND
RP   GLU-34.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT TRP-5.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-5.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS), FUNCTION, KINETIC PARAMETERS,
RP   MUTAGENESIS OF SER-111; ASP-228; HIS-283 AND HIS-287, GLYCOSYLATION AT
RP   ASN-190, AND DISULFIDE BONDS.
RX   PubMed=12855696; DOI=10.1074/jbc.m301225200;
RA   Calero G., Gupta P., Nonato M.C., Tandel S., Biehl E.R., Hofmann S.L.,
RA   Clardy J.;
RT   "The crystal structure of palmitoyl protein thioesterase-2 (PPT2) reveals
RT   the basis for divergent substrate specificities of the two lysosomal
RT   thioesterases, PPT1 and PPT2.";
RL   J. Biol. Chem. 278:37957-37964(2003).
RN   [14]
RP   VARIANTS TRP-5 AND GLU-34.
RX   PubMed=10051407; DOI=10.1006/geno.1998.5703;
RA   Soyombo A.A., Yi W., Hofmann S.L.;
RT   "Structure of the human palmitoyl-protein thioesterase-2 gene (PPT2) in the
RT   major histocompatibility complex on chromosome 6p21.3.";
RL   Genomics 56:208-216(1999).
CC   -!- FUNCTION: Removes thioester-linked fatty acyl groups from various
CC       substrates including S-palmitoyl-CoA. Has the highest S-thioesterase
CC       activity for the acyl groups palmitic and myristic acid followed by
CC       other short- and long-chain acyl substrates. However, because of
CC       structural constraints, is unable to remove palmitate from peptides or
CC       proteins. {ECO:0000269|PubMed:10417332, ECO:0000269|PubMed:12855696,
CC       ECO:0000269|PubMed:9341199}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=67 uM for S-palmitoyl-CoA {ECO:0000269|PubMed:12855696};
CC         KM=37 uM for S-palmitoyl-N-acetylcysteamine
CC         {ECO:0000269|PubMed:12855696};
CC         KM=117 uM for 4-methylumbelliferyl-6-S-palmitoyl-beta-D-
CC         glucopyranoside {ECO:0000269|PubMed:12855696};
CC         Vmax=1.7 umol/min/mg enzyme toward S-palmitoyl-CoA
CC         {ECO:0000269|PubMed:12855696};
CC         Vmax=3.3 umol/min/mg enzyme toward S-palmitoyl-N-acetylcysteamine
CC         {ECO:0000269|PubMed:12855696};
CC         Vmax=0.43 umol/min/mg enzyme toward 4-methylumbelliferyl-6-S-
CC         palmitoyl-beta-D-glucopyranoside {ECO:0000269|PubMed:12855696};
CC       pH dependence:
CC         Optimum pH is 7.0. {ECO:0000269|PubMed:9341199};
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:9341199}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UMR5-1; Sequence=Displayed;
CC       Name=2; Synonyms=I;
CC         IsoId=Q9UMR5-2; Sequence=VSP_005188;
CC       Name=3;
CC         IsoId=Q9UMR5-3; Sequence=VSP_054027;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in skeletal
CC       muscle. {ECO:0000269|PubMed:9341199}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Catalytically inactive due to lack of His-
CC       283. May be produced at very low levels due to a premature stop codon
CC       in the mRNA, leading to nonsense-mediated mRNA decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the palmitoyl-protein thioesterase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally referred as a palmitoyl-protein thioesterase
CC       (palmitoyl-protein hydrolase). {ECO:0000305|PubMed:9341199}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAG38577.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF020543; AAB80730.1; -; mRNA.
DR   EMBL; AF020544; AAB80731.1; -; mRNA.
DR   EMBL; Y17958; CAB46981.1; -; mRNA.
DR   EMBL; AL110128; CAB53659.1; -; mRNA.
DR   EMBL; CR533546; CAG38577.1; ALT_INIT; mRNA.
DR   EMBL; AK292729; BAF85418.1; -; mRNA.
DR   EMBL; U89336; AAB47495.1; -; Genomic_DNA.
DR   EMBL; AL662828; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL662884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL845464; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX284686; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX927239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR753803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR812478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR933878; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03597.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03591.1; -; Genomic_DNA.
DR   EMBL; BC001355; AAH01355.1; -; mRNA.
DR   CCDS; CCDS4740.1; -. [Q9UMR5-3]
DR   CCDS; CCDS4742.1; -. [Q9UMR5-1]
DR   RefSeq; NP_001191032.1; NM_001204103.1. [Q9UMR5-1]
DR   RefSeq; NP_005146.4; NM_005155.6. [Q9UMR5-1]
DR   RefSeq; NP_619731.2; NM_138717.2. [Q9UMR5-3]
DR   PDB; 1PJA; X-ray; 2.70 A; A=1-302.
DR   PDBsum; 1PJA; -.
DR   SMR; Q9UMR5; -.
DR   BioGRID; 114775; 37.
DR   IntAct; Q9UMR5; 9.
DR   STRING; 9606.ENSP00000354608; -.
DR   ChEMBL; CHEMBL2189137; -.
DR   ESTHER; human-PPT2; Palmitoyl-protein_thioesterase.
DR   GlyGen; Q9UMR5; 5 sites.
DR   iPTMnet; Q9UMR5; -.
DR   BioMuta; PPT2; -.
DR   DMDM; 296453016; -.
DR   EPD; Q9UMR5; -.
DR   jPOST; Q9UMR5; -.
DR   MassIVE; Q9UMR5; -.
DR   PaxDb; Q9UMR5; -.
DR   PeptideAtlas; Q9UMR5; -.
DR   PRIDE; Q9UMR5; -.
DR   ProteomicsDB; 34200; -.
DR   ProteomicsDB; 85198; -. [Q9UMR5-1]
DR   ProteomicsDB; 85199; -. [Q9UMR5-2]
DR   Antibodypedia; 45479; 121 antibodies.
DR   DNASU; 9374; -.
DR   Ensembl; ENST00000324816; ENSP00000320528; ENSG00000221988. [Q9UMR5-1]
DR   Ensembl; ENST00000361568; ENSP00000354608; ENSG00000221988. [Q9UMR5-3]
DR   Ensembl; ENST00000375137; ENSP00000364279; ENSG00000221988. [Q9UMR5-1]
DR   Ensembl; ENST00000375143; ENSP00000364285; ENSG00000221988. [Q9UMR5-1]
DR   Ensembl; ENST00000383301; ENSP00000372789; ENSG00000206329.
DR   Ensembl; ENST00000395523; ENSP00000378894; ENSG00000221988. [Q9UMR5-1]
DR   Ensembl; ENST00000412651; ENSP00000416505; ENSG00000236649.
DR   Ensembl; ENST00000414356; ENSP00000398462; ENSG00000168452.
DR   Ensembl; ENST00000415972; ENSP00000408333; ENSG00000228116.
DR   Ensembl; ENST00000423347; ENSP00000406219; ENSG00000231618.
DR   Ensembl; ENST00000433748; ENSP00000410001; ENSG00000206256.
DR   Ensembl; ENST00000476214; ENSP00000432308; ENSG00000168452.
DR   Ensembl; ENST00000480383; ENSP00000432502; ENSG00000236649.
DR   Ensembl; ENST00000483565; ENSP00000431928; ENSG00000231618.
DR   Ensembl; ENST00000488579; ENSP00000434992; ENSG00000236649.
DR   Ensembl; ENST00000490624; ENSP00000433323; ENSG00000168452.
DR   Ensembl; ENST00000493809; ENSP00000436963; ENSG00000227600.
DR   Ensembl; ENST00000496937; ENSP00000432964; ENSG00000231618.
DR   Ensembl; ENST00000527704; ENSP00000433061; ENSG00000227600.
DR   GeneID; 9374; -.
DR   KEGG; hsa:9374; -.
DR   UCSC; uc003nzw.4; human. [Q9UMR5-1]
DR   CTD; 9374; -.
DR   DisGeNET; 9374; -.
DR   GeneCards; PPT2; -.
DR   HGNC; HGNC:9326; PPT2.
DR   HPA; ENSG00000221988; Low tissue specificity.
DR   MIM; 603298; gene.
DR   neXtProt; NX_Q9UMR5; -.
DR   OpenTargets; ENSG00000221988; -.
DR   OpenTargets; ENSG00000258388; -.
DR   PharmGKB; PA33689; -.
DR   VEuPathDB; HostDB:ENSG00000221988.12; -.
DR   eggNOG; KOG2541; Eukaryota.
DR   GeneTree; ENSGT00940000155779; -.
DR   HOGENOM; CLU_050129_1_0_1; -.
DR   InParanoid; Q9UMR5; -.
DR   OMA; AWHTRRD; -.
DR   OrthoDB; 836806at2759; -.
DR   PhylomeDB; Q9UMR5; -.
DR   TreeFam; TF323926; -.
DR   PathwayCommons; Q9UMR5; -.
DR   Reactome; R-HSA-75105; Fatty acyl-CoA biosynthesis.
DR   BioGRID-ORCS; 9374; 14 hits in 879 CRISPR screens.
DR   EvolutionaryTrace; Q9UMR5; -.
DR   GeneWiki; PPT2; -.
DR   GenomeRNAi; 9374; -.
DR   Pharos; Q9UMR5; Tbio.
DR   PRO; PR:Q9UMR5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9UMR5; protein.
DR   Bgee; ENSG00000221988; Expressed in secondary oocyte and 211 other tissues.
DR   ExpressionAtlas; Q9UMR5; baseline and differential.
DR   Genevisible; Q9UMR5; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0098599; F:palmitoyl hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0008474; F:palmitoyl-(protein) hydrolase activity; IEA:InterPro.
DR   GO; GO:0016790; F:thiolester hydrolase activity; IBA:GO_Central.
DR   GO; GO:0046949; P:fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002472; Palm_thioest.
DR   InterPro; IPR030295; PPT2.
DR   PANTHER; PTHR11247:SF27; PTHR11247:SF27; 1.
DR   PRINTS; PR00414; PPTHIESTRASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Hydrolase; Lysosome; Reference proteome; Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..302
FT                   /note="Lysosomal thioesterase PPT2"
FT                   /id="PRO_0000025554"
FT   ACT_SITE        111
FT                   /note="Nucleophile"
FT   ACT_SITE        228
FT   ACT_SITE        283
FT   CARBOHYD        60
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        190
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   CARBOHYD        206
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        245
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        289
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        109..117
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   DISULFID        165..176
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   DISULFID        276..296
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   VAR_SEQ         1
FT                   /note="M -> MKSCGSM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11230166"
FT                   /id="VSP_054027"
FT   VAR_SEQ         256..300
FT                   /note="VYLRDSFGLKTLLARGAIVRCPMAGISHTAWHSNRTLYETCIEPW -> PAR
FT                   PTHQSELLLLRLVCLKPPRRKKPACRVQRQSESWGPGLSCA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9341199"
FT                   /id="VSP_005188"
FT   VARIANT         5
FT                   /note="C -> W (in dbSNP:rs3134604)"
FT                   /evidence="ECO:0000269|PubMed:10051407,
FT                   ECO:0000269|PubMed:10417332, ECO:0000269|PubMed:11230166,
FT                   ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:14656967,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9341199, ECO:0000269|Ref.4,
FT                   ECO:0000269|Ref.8"
FT                   /id="VAR_027107"
FT   VARIANT         34
FT                   /note="A -> E (in dbSNP:rs3096696)"
FT                   /evidence="ECO:0000269|PubMed:10051407,
FT                   ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:14656967"
FT                   /id="VAR_027108"
FT   MUTAGEN         111
FT                   /note="S->A: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   MUTAGEN         228
FT                   /note="D->A: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   MUTAGEN         283
FT                   /note="H->A: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   MUTAGEN         287
FT                   /note="H->A: No effect on enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:12855696"
FT   CONFLICT        189
FT                   /note="L -> P (in Ref. 4; CAG38577)"
FT                   /evidence="ECO:0000305"
FT   STRAND          39..42
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           49..52
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           53..62
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   STRAND          68..70
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           77..80
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           83..100
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   STRAND          105..110
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           112..123
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   STRAND          129..136
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           147..152
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           158..165
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           170..172
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           175..178
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           185..191
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           195..198
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           207..214
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   STRAND          218..224
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   STRAND          229..233
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           234..238
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           251..253
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           255..258
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   TURN            259..262
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           264..269
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   STRAND          273..277
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   TURN            283..287
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           290..296
FT                   /evidence="ECO:0000244|PDB:1PJA"
FT   HELIX           298..300
FT                   /evidence="ECO:0000244|PDB:1PJA"
SQ   SEQUENCE   302 AA;  34225 MW;  E242D677970B4BEA CRC64;
     MLGLCGQRLP AAWVLLLLPF LPLLLLAAPA PHRASYKPVI VVHGLFDSSY SFRHLLEYIN
     ETHPGTVVTV LDLFDGRESL RPLWEQVQGF REAVVPIMAK APQGVHLICY SQGGLVCRAL
     LSVMDDHNVD SFISLSSPQM GQYGDTDYLK WLFPTSMRSN LYRICYSPWG QEFSICNYWH
     DPHHDDLYLN ASSFLALING ERDHPNATVW RKNFLRVGHL VLIGGPDDGV ITPWQSSFFG
     FYDANETVLE MEEQLVYLRD SFGLKTLLAR GAIVRCPMAG ISHTAWHSNR TLYETCIEPW
     LS
//
ID   PTCD3_HUMAN             Reviewed;         689 AA.
AC   Q96EY7; A6NHD2; D6W5M1; Q597H0; Q658Y9; Q9BUZ8; Q9NWL0;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 3.
DT   10-FEB-2021, entry version 165.
DE   RecName: Full=Pentatricopeptide repeat domain-containing protein 3, mitochondrial;
DE   AltName: Full=28S ribosomal protein S39, mitochondrial;
DE            Short=MRP-S39;
DE   AltName: Full=Mitochondrial small ribosomal subunit protein mS39 {ECO:0000303|PubMed:25838379};
DE   AltName: Full=Transformation-related gene 15 protein;
DE            Short=TRG-15;
DE   Flags: Precursor;
GN   Name=PTCD3; Synonyms=MRPS39; ORFNames=TRG15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 311-689.
RC   TISSUE=Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 323-689.
RA   Kim J.W.;
RT   "Identification of a human transforming gene.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   TISSUE SPECIFICITY, SUBUNIT, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=19427859; DOI=10.1016/j.febslet.2009.04.048;
RA   Davies S.M., Rackham O., Shearwood A.M., Hamilton K.L., Narsai R.,
RA   Whelan J., Filipovska A.;
RT   "Pentatricopeptide repeat domain protein 3 associates with the
RT   mitochondrial small ribosomal subunit and regulates translation.";
RL   FEBS Lett. 583:1853-1858(2009).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-126, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=23908630; DOI=10.3389/fphys.2013.00183;
RA   Koc E.C., Cimen H., Kumcuoglu B., Abu N., Akpinar G., Haque M.E.,
RA   Spremulli L.L., Koc H.;
RT   "Identification and characterization of CHCHD1, AURKAIP1, and CRIF1 as new
RT   members of the mammalian mitochondrial ribosome.";
RL   Front. Physiol. 4:183-183(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=25838379; DOI=10.1126/science.aaa1193;
RA   Amunts A., Brown A., Toots J., Scheres S.H., Ramakrishnan V.;
RT   "Ribosome. The structure of the human mitochondrial ribosome.";
RL   Science 348:95-98(2015).
CC   -!- FUNCTION: Mitochondrial RNA-binding protein that has a role in
CC       mitochondrial translation. {ECO:0000269|PubMed:19427859}.
CC   -!- SUBUNIT: Component of the mitochondrial small ribosomal subunit (mt-
CC       SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small
CC       (28S) and a large (39S) subunit. The 28S small subunit contains a 12S
CC       ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large
CC       subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial
CC       valine transfer RNA (mt-tRNA(Val)), which plays an integral structural
CC       role, and 52 different proteins. Associated with the 12S mitochondrial
CC       rRNA (12S mt-rRNA). {ECO:0000269|PubMed:19427859,
CC       ECO:0000269|PubMed:23908630, ECO:0000269|PubMed:25838379}.
CC   -!- INTERACTION:
CC       Q96EY7; Q8N448: LNX2; NbExp=3; IntAct=EBI-721110, EBI-2340947;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:19427859,
CC       ECO:0000269|PubMed:23908630}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96EY7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96EY7-2; Sequence=VSP_028191, VSP_028192;
CC   -!- TISSUE SPECIFICITY: Abundant in testes, skeletal muscle and heart
CC       tissue. {ECO:0000269|PubMed:19427859}.
CC   -!- SIMILARITY: Belongs to the mitochondrion-specific ribosomal protein
CC       mS39 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK000765; BAA91370.1; -; mRNA.
DR   EMBL; AC009309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAW99464.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99465.1; -; Genomic_DNA.
DR   EMBL; BC001758; AAH01758.3; -; mRNA.
DR   EMBL; BC011832; AAH11832.3; -; mRNA.
DR   EMBL; AL832520; CAH56345.1; -; mRNA.
DR   EMBL; AY277598; AAQ18037.1; -; mRNA.
DR   CCDS; CCDS33235.1; -. [Q96EY7-1]
DR   RefSeq; NP_060422.4; NM_017952.5. [Q96EY7-1]
DR   PDB; 3J9M; EM; 3.50 A; A4=1-689.
DR   PDB; 6NU2; EM; 3.90 A; A4=56-639.
DR   PDB; 6NU3; EM; 4.40 A; A4=56-639.
DR   PDB; 6RW4; EM; 2.97 A; 4=1-689.
DR   PDB; 6RW5; EM; 3.14 A; 4=1-689.
DR   PDB; 6VLZ; EM; 2.97 A; A4=1-689.
DR   PDB; 6VMI; EM; 2.96 A; A4=1-689.
DR   PDB; 6ZS9; EM; 4.00 A; A4=56-689.
DR   PDB; 6ZSA; EM; 4.00 A; A4=56-689.
DR   PDB; 6ZSB; EM; 4.50 A; A4=56-689.
DR   PDB; 6ZSC; EM; 3.50 A; A4=56-689.
DR   PDB; 6ZSD; EM; 3.70 A; A4=56-689.
DR   PDB; 6ZSE; EM; 5.00 A; A4=56-689.
DR   PDB; 6ZSG; EM; 4.00 A; A4=56-689.
DR   PDBsum; 3J9M; -.
DR   PDBsum; 6NU2; -.
DR   PDBsum; 6NU3; -.
DR   PDBsum; 6RW4; -.
DR   PDBsum; 6RW5; -.
DR   PDBsum; 6VLZ; -.
DR   PDBsum; 6VMI; -.
DR   PDBsum; 6ZS9; -.
DR   PDBsum; 6ZSA; -.
DR   PDBsum; 6ZSB; -.
DR   PDBsum; 6ZSC; -.
DR   PDBsum; 6ZSD; -.
DR   PDBsum; 6ZSE; -.
DR   PDBsum; 6ZSG; -.
DR   SMR; Q96EY7; -.
DR   BioGRID; 120366; 152.
DR   ComplexPortal; CPX-5225; 28S mitochondrial small ribosomal subunit.
DR   CORUM; Q96EY7; -.
DR   IntAct; Q96EY7; 89.
DR   MINT; Q96EY7; -.
DR   STRING; 9606.ENSP00000254630; -.
DR   iPTMnet; Q96EY7; -.
DR   MetOSite; Q96EY7; -.
DR   PhosphoSitePlus; Q96EY7; -.
DR   SwissPalm; Q96EY7; -.
DR   BioMuta; PTCD3; -.
DR   DMDM; 74731633; -.
DR   EPD; Q96EY7; -.
DR   jPOST; Q96EY7; -.
DR   MassIVE; Q96EY7; -.
DR   MaxQB; Q96EY7; -.
DR   PaxDb; Q96EY7; -.
DR   PeptideAtlas; Q96EY7; -.
DR   PRIDE; Q96EY7; -.
DR   ProteomicsDB; 76472; -. [Q96EY7-1]
DR   ProteomicsDB; 76473; -. [Q96EY7-2]
DR   Antibodypedia; 32009; 61 antibodies.
DR   Ensembl; ENST00000254630; ENSP00000254630; ENSG00000132300. [Q96EY7-1]
DR   GeneID; 55037; -.
DR   KEGG; hsa:55037; -.
DR   UCSC; uc002sqw.2; human. [Q96EY7-1]
DR   CTD; 55037; -.
DR   DisGeNET; 55037; -.
DR   GeneCards; PTCD3; -.
DR   HGNC; HGNC:24717; PTCD3.
DR   HPA; ENSG00000132300; Low tissue specificity.
DR   MIM; 614918; gene.
DR   neXtProt; NX_Q96EY7; -.
DR   OpenTargets; ENSG00000132300; -.
DR   PharmGKB; PA147357465; -.
DR   VEuPathDB; HostDB:ENSG00000132300.18; -.
DR   eggNOG; KOG4422; Eukaryota.
DR   GeneTree; ENSGT00390000016876; -.
DR   HOGENOM; CLU_026264_0_1_1; -.
DR   InParanoid; Q96EY7; -.
DR   OMA; FMHQEAQ; -.
DR   OrthoDB; 405419at2759; -.
DR   PhylomeDB; Q96EY7; -.
DR   TreeFam; TF320158; -.
DR   PathwayCommons; Q96EY7; -.
DR   Reactome; R-HSA-5368286; Mitochondrial translation initiation.
DR   Reactome; R-HSA-5389840; Mitochondrial translation elongation.
DR   Reactome; R-HSA-5419276; Mitochondrial translation termination.
DR   SIGNOR; Q96EY7; -.
DR   BioGRID-ORCS; 55037; 399 hits in 879 CRISPR screens.
DR   ChiTaRS; PTCD3; human.
DR   GenomeRNAi; 55037; -.
DR   Pharos; Q96EY7; Tbio.
DR   PRO; PR:Q96EY7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q96EY7; protein.
DR   Bgee; ENSG00000132300; Expressed in adrenal tissue and 238 other tissues.
DR   ExpressionAtlas; Q96EY7; baseline and differential.
DR   Genevisible; Q96EY7; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005840; C:ribosome; IEA:UniProtKB-KW.
DR   GO; GO:0043024; F:ribosomal small subunit binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0019843; F:rRNA binding; IDA:UniProtKB.
DR   GO; GO:0032543; P:mitochondrial translation; IMP:UniProtKB.
DR   GO; GO:0070125; P:mitochondrial translational elongation; TAS:Reactome.
DR   GO; GO:0070126; P:mitochondrial translational termination; TAS:Reactome.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.40.10; -; 2.
DR   InterPro; IPR002885; Pentatricopeptide_repeat.
DR   InterPro; IPR037387; PTCD3.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   PANTHER; PTHR16276; PTHR16276; 1.
DR   Pfam; PF13041; PPR_2; 1.
DR   Pfam; PF13812; PPR_3; 1.
DR   PROSITE; PS51375; PPR; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Mitochondrion;
KW   Reference proteome; Repeat; Ribonucleoprotein; Ribosomal protein;
KW   RNA-binding; rRNA-binding; Transit peptide; Translation regulation.
FT   TRANSIT         1..37
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           38..689
FT                   /note="Pentatricopeptide repeat domain-containing protein
FT                   3, mitochondrial"
FT                   /id="PRO_0000305028"
FT   REPEAT          149..183
FT                   /note="PPR 1"
FT   REPEAT          184..219
FT                   /note="PPR 2"
FT   REPEAT          255..289
FT                   /note="PPR 3"
FT   REPEAT          290..330
FT                   /note="PPR 4"
FT   REPEAT          331..367
FT                   /note="PPR 5"
FT   REPEAT          368..409
FT                   /note="PPR 6"
FT   REPEAT          412..446
FT                   /note="PPR 7"
FT   REPEAT          454..488
FT                   /note="PPR 8"
FT   REPEAT          489..523
FT                   /note="PPR 9"
FT   REPEAT          572..606
FT                   /note="PPR 10"
FT   MOD_RES         126
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   VAR_SEQ         1..409
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028191"
FT   VAR_SEQ         410..413
FT                   /note="PDDD -> MMAY (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028192"
FT   VARIANT         2
FT                   /note="A -> V (in dbSNP:rs13393659)"
FT                   /id="VAR_035154"
FT   VARIANT         681
FT                   /note="S -> G (in dbSNP:rs2241433)"
FT                   /id="VAR_035155"
FT   CONFLICT        400
FT                   /note="L -> S (in Ref. 6; AAQ18037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        488
FT                   /note="P -> L (in Ref. 4; AAH01758)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   689 AA;  78550 MW;  901DBE1FF3A2E0B9 CRC64;
     MAVVSAVRWL GLRSRLGQPL TGRRAGLCEQ ARSCRFYSGS ATLSKVEGTD VTGIEEVVIP
     KKKTWDKVAV LQALASTVNR DTTAVPYVFQ DDPYLMPASS LESRSFLLAK KSGENVAKFI
     INSYPKYFQK DIAEPHIPCL MPEYFEPQIK DISEAALKER IELRKVKASV DMFDQLLQAG
     TTVSLETTNS LLDLLCYYGD QEPSTDYHFQ QTGQSEALEE ENDETSRRKA GHQFGVTWRA
     KNNAERIFSL MPEKNEHSYC TMIRGMVKHR AYEQALNLYT ELLNNRLHAD VYTFNALIEA
     TVCAINEKFE EKWSKILELL RHMVAQKVKP NLQTFNTILK CLRRFHVFAR SPALQVLREM
     KAIGIEPSLA TYHHIIRLFD QPGDPLKRSS FIIYDIMNEL MGKRFSPKDP DDDKFFQSAM
     SICSSLRDLE LAYQVHGLLK TGDNWKFIGP DQHRNFYYSK FFDLICLMEQ IDVTLKWYED
     LIPSAYFPHS QTMIHLLQAL DVANRLEVIP KIWKDSKEYG HTFRSDLREE ILMLMARDKH
     PPELQVAFAD CAADIKSAYE SQPIRQTAQD WPATSLNCIA ILFLRAGRTQ EAWKMLGLFR
     KHNKIPRSEL LNELMDSAKV SNSPSQAIEV VELASAFSLP ICEGLTQRVM SDFAINQEQK
     EALSNLTALT SDSDTDSSSD SDSDTSEGK
//
